{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:51:11Z","timestamp":1794552671170,"version":"4.9.1"},"reference-count":1076,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpsychires.2025.12.039","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:12:44Z","timestamp":1768691564000},"page":"404-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-5184","authenticated-orcid":false,"given":"Michael","family":"Van Ameringen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi A.","family":"Fineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasios","family":"Brakoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yekta","family":"Dowlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casara J.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Feusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael C.R.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benicio N.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Giacobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Goldman","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Hopkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McQuay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Menchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Minuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Mojgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis N.","family":"Mpavaenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pallanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pampaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn I.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Smigielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smadar Val\u00e9rie","family":"Tourjman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Roessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone N.","family":"Vigod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Walitza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi N.","family":"Yatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moren\u00e1","family":"Zugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Maria","family":"Dell\u2019Osso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2025.12.039_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/jclp.20423","article-title":"Obsessive\u2013compulsive disorder and romantic functioning","volume":"63","author":"Abbey","year":"2007","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08098131.2018.1546222","article-title":"Effects of music as an adjunctive therapy on severity of symptoms in patients with obsessive-compulsive disorder: Randomized controlled trial","volume":"28","author":"Abdulah","year":"2019","journal-title":"Nord. J. Music Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2022.102532","article-title":"A revision of the Obsessive-Compulsive Inventory - Child Version: The OCI-CV-R","volume":"86","author":"Abramovitch","year":"2022","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cpr.2013.09.004","article-title":"The neuropsychology of adult obsessive\u2013compulsive disorder: A meta-analysis","volume":"33","author":"Abramovitch","year":"2013","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/HRP.0000000000000050","article-title":"Comorbidity Between Attention Deficit\/Hyperactivity Disorder and Obsessive-Compulsive Disorder Across the Lifespan: A Systematic and Critical Review","volume":"23","author":"Abramovitch","year":"2015","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.beth.2013.02.005","article-title":"Treating obsessive-compulsive disorder in intimate relationships: a pilot study of couple-based cognitive-behavior therapy","volume":"44","author":"Abramowitz","year":"2013","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0145445512444596","article-title":"Enhancing exposure and response prevention for OCD: a couple-based approach","volume":"37","author":"Abramowitz","year":"2013","journal-title":"Behav. Modif."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/16506070510041202","article-title":"Potentials and limitations of cognitive treatments for obsessive-compulsive disorder","volume":"34","author":"Abramowitz","year":"2005","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.genhosppsych.2017.06.010","article-title":"A pilot randomized controlled trial of aerobic exercise as an adjunct to OCD treatment","volume":"49","author":"Abrantes","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jad.2018.11.074","article-title":"Acute effects of aerobic exercise on negative affect and obsessions and compulsions in individuals with obsessive-compulsive disorder","volume":"245","author":"Abrantes","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.janxdis.2009.06.008","article-title":"Acute changes in obsessions and compulsions following moderate-intensity aerobic exercise among patients with obsessive-compulsive disorder","volume":"23","author":"Abrantes","year":"2009","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00004714-199806000-00002","article-title":"Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder","volume":"18","author":"Ackerman","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000000659","article-title":"Intranasal ketamine and cognitive-behavioral therapy for treatment-refractory obsessive-compulsive disorder","author":"Adams","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib14","first-page":"976","article-title":"Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial","volume":"19","author":"Afshar","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0b013e318272677d","article-title":"N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial","author":"Afshar","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib16","first-page":"291","article-title":"Treatment of obsessive compulsive symptoms in schizophrenia with fluoxetine","volume":"42","author":"Agarwal","year":"2000","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib17","doi-asserted-by":"crossref","DOI":"10.30773\/pi.2017.06.17.2","article-title":"The impact of general medical conditions in obsessive-compulsive disorder","author":"Aguglia","year":"2018","journal-title":"Psychiatr. Investigation"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib18","first-page":"S3","article-title":"Adjunctive troriluzole-a novel glutamate modulator-in patients with obsessive compulsive disorder: Impact of baseline disease severity on treatment outcomes","volume":"18","author":"Aguiar","year":"2021","journal-title":"Innovat. Clin. Neurosci. CNS Summit"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2017.06.004","article-title":"Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial","author":"Ahmadpanah","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/abr.abr_114_16","article-title":"The effect of atorvastatin on obsessive-compulsive symptoms of refractory obsessive-compulsive disorder (add-on therapy)","volume":"7","author":"Akouchekian","year":"2018","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib21","first-page":"59","article-title":"Comparison of the effectiveness of behavioural- cognitive & behavioural- metacognitive approaches in patients with obsessive- compulsive disorder (OCD)","volume":"2","author":"Akrami","year":"2010","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib22","article-title":"Sexuality in women with obsessive compulsive disorder","volume":"27","author":"Aksaray","year":"2001","journal-title":"J. Sex Marital Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3928\/00485713-20201005-01","article-title":"Safe and Effective Use of Venlafaxine, Mirtazapine, and Aripiprazole in an Adolescent with Treatment-Resistant Obsessive-Compulsive Disorder","volume":"50","author":"Aksu","year":"2020","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4088\/JCP.v63n1108","article-title":"Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study","volume":"63","author":"Albert","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/PRBM.S124359","article-title":"Family accommodation in adult obsessive-compulsive disorder: clinical perspectives","volume":"10","author":"Albert","year":"2017","journal-title":"Psychol. Res. Behav. Manag."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eurpsy.2019.01.017","article-title":"Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder","volume":"58","author":"Albert","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib27","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1016\/S0924-977X(03)92129-8","article-title":"P.3.009 Cognitive-behavioral therapy in obsessive-compulsive disorder patients partially unresponsive to SRIs","volume":"13","author":"Albert","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib28","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X16666180620155941","article-title":"Suicide risk in obsessive-compulsive disorder and exploration of risk factors: A systematic review","author":"Albert","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib29","first-page":"75","article-title":"Electroconvulsive therapy and schizophrenia: A systematic review","volume":"5","author":"Ali","year":"2019","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib30","doi-asserted-by":"crossref","DOI":"10.15412\/J.JPCP.06040201","article-title":"The effects of transcranial direct current stimulation on obsession-compulsion, anxiety, and depression of a patient suffering from obsessive-compulsive disorder","author":"Alizadehgoradel","year":"2016","journal-title":"Practice Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133591","article-title":"Deep brain stimulation for obsessive-compulsive disorder: A meta-analysis of treatment outcome and predictors of response","volume":"10","author":"Alonso","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/appi.ajp.158.7.1143","article-title":"Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study","volume":"158","author":"Alonso","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/WNF.0000000000000578","article-title":"Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review","author":"Alves-Pereira","year":"2024","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2014.05.026","article-title":"Treatment of comorbid bipolar disorder and obsessive\u2013compulsive disorder: A systematic review","volume":"166","author":"Amerio","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2008.01.006","article-title":"Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study","author":"Amiaz","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-3-16","article-title":"Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders : a randomized controlled trial","volume":"3","author":"Anagnostou","year":"2012","journal-title":"Mol. Autism"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.janxdis.2011.05.007","article-title":"Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study","volume":"25","author":"Anand","year":"2011","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0364-7722(81)90077-1","article-title":"Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis","volume":"5","author":"Ananth","year":"1981","journal-title":"Prog. Neuro Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.brat.2006.01.016","article-title":"Group versus individual cognitive-behavioural treatment for obsessive-compulsive disorder: a controlled trial","volume":"45","author":"Anderson","year":"2007","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib40","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1017\/S0033291712000244","article-title":"Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial","volume":"42","author":"Andersson","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2015.0546","article-title":"D-cycloserine vs placebo as adjunct to cognitive behavioral therapy for obsessive-compulsive disorder and interaction with antidepressants: A randomized clinical trial","author":"Andersson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-244X-11-125","article-title":"Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study","volume":"11","author":"Andersson","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib43","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1017\/S0033291714000543","article-title":"Long-term efficacy of internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: A randomized controlled trial","volume":"44","author":"Andersson","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/wps.20610","article-title":"Internet-delivered psychological treatments: from innovation to implementation","volume":"18","author":"Andersson","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib45","first-page":"11","article-title":"The efficacy of metacognitive therapy on patients suffering from pure obsession","volume":"7","author":"Andouz","year":"2012","journal-title":"Iran. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/sltb.12593","article-title":"Obsessive-compulsive disorder and suicidal experiences: the role of experiential avoidance","author":"Angelakis","year":"2020","journal-title":"Suicide Life-Threatening Behav."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-019-1020-5","article-title":"Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations","volume":"21","author":"Antshel","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2584","article-title":"L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study","volume":"32","author":"Arabzadeh","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib51","first-page":"367","article-title":"Efficacy of citalopram in treatment OF pathological SKIN PICKING, a randomized double blind placebo controlled trial","author":"Arbabi","year":"2008","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jocrd.2014.12.002","article-title":"Exposure therapy for obsessive\u2013compulsive disorder: An optimizing inhibitory learning approach","volume":"6","author":"Arch","year":"2015","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib53","article-title":"Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive\u2013Compulsive Disorder in Childhood","volume":"48","author":"Ardic","year":"2016","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib54","article-title":"A Case Series of Women With Postpartum-Onset Obsessive-Compulsive Disorder","volume":"1","author":"Arnold","year":"1999","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-199902000-00005","article-title":"An Open Clinical Trial of Fluvoxamine Treatment of Psychogenic Excoriation","volume":"19","author":"Arnold","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/YCT.0000000000000509","article-title":"Augmentation effect of low-frequency repetitive transcranial magnetic stimulation over presupplementary motor area in obsessive-compulsive disorder: A randomized controlled trial","volume":"34","author":"Arumugham","year":"2018","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib57","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.chi.0000177324.40005.6f","article-title":"Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents With obsessive-compulsive disorder","volume":"44","author":"Asbahr","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpn.2020.09.004","article-title":"Deep brain stimulation in the management of paediatric neuropsychiatric conditions: Current evidence and future directions","volume":"33","author":"Ashkan","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib59","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/11635850-000000000-00000","article-title":"Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial","volume":"26","author":"Askari","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib60","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2021.3839","article-title":"Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial","volume":"325","author":"Aspvall","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib61","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5TM","year":"2013"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib62","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib63","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00005053-199110000-00009","article-title":"Three Cases of Pharmacotherapy of Obsessive- Compulsive Disorder in the Elderly","volume":"179","author":"Austin","year":"1991","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13554794.2017.1361451","article-title":"Enhanced cognition and emotional recognition, and reduced obsessive compulsive symptoms in two adults with high-functioning autism as a result of deep Transcranial Magnetic Stimulation (dTMS): a case report","volume":"23","author":"Avirame","year":"2017","journal-title":"Neurocase"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2017.12.054","article-title":"Relationship between childhood trauma and suicide probability in obsessive-compulsive disorder","author":"Ay","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib66","first-page":"393","article-title":"Efficacy of repetitive transcranial magnetic stimulation in the management of obsessive compulsive disorder","volume":"47","author":"Badawy","year":"2010","journal-title":"Egypt. J. Neurol. Psychiatr. Neurosurg."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib67","series-title":"Behavior therapy for obsessive compulsive disorder in the office-based practice","author":"Baer","year":"1993"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib68","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1176\/ajp.150.11.1737","article-title":"Computer-assisted telephone administration of a structured interview for obsessive-compulsive disorder","volume":"150","author":"Baer","year":"1993","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/gps.930070212","article-title":"Obsessive compulsive disorder arising in a 75-year-old woman","volume":"7","author":"Bajulaiye","year":"1992","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/JCP.0000000000000989","article-title":"Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor\u2013Resistant Obsessive-Compulsive Disorder: Experience From a Specialty Clinic in India","volume":"39","author":"Balachander","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib71","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2147\/NDT.S36453","article-title":"Pregabalin for the treatment of generalized anxiety disorder: an update","volume":"9","author":"Baldwin","year":"2013","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib73","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00406-021-01324-1","article-title":"The German Guidelines for the treatment of anxiety disorders: first revision","volume":"272","author":"Bandelow","year":"2022","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113826","article-title":"Examining the correlation between symptoms of obsessive compulsive disorder and autism spectrum disorder in a community-based sample of adults","volume":"299","author":"Barnard-Brak","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004583-200401000-00014","article-title":"Cognitive-Behavioral Family Treatment of Childhood Obsessive-Compulsive Disorder: A Controlled Trial","volume":"43","author":"Barrett","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib76","first-page":"1","article-title":"Examination of the effectiveness of mindfulness-based cognitive therapy on patients with obsessive-compulsive disorder: systematic review and meta-analysis","author":"Baskaya","year":"2021","journal-title":"Issues Ment. Health Nurs."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpsy.2019.08.011","article-title":"Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial","author":"Bation","year":"2019","journal-title":"Eur. Psychiatry : J. Assoc. European Psychiatrists"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib78","article-title":"Transcranial direct current stimulation in treatment-resistant obsessive-compulsive disorder: An open-label pilot study","author":"Bation","year":"2015","journal-title":"Progress neuro-Psychopharmacol. Biological Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"Beach","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib80","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.4088\/JCP.13r08672","article-title":"Meta-Analysis of Selective Serotonin Reuptake Inhibitor\u2013Associated QTc Prolongation","volume":"75","author":"Beach","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/02698811241301215","article-title":"Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study","volume":"39","author":"Beaglehole","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112583","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder","author":"Beaulieu","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-020-01176-x","article-title":"Co-occurrence, Assessment and Treatment of Obsessive Compulsive Disorder in Children and Adults With Autism Spectrum Disorder","volume":"22","author":"Bedford","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib84","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M","article-title":"Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam","volume":"13","author":"Beekman","year":"1998","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib85","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpsychires.2022.12.003","article-title":"Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients","volume":"158","author":"Bejerot","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib86","article-title":"Feasibility, Acceptability and Preliminary Efficacy of Dialectical Behavior Therapy for Autistic Adults without Intellectual Disability: A Mixed Methods Study","author":"Bemmouna","year":"2021","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00720","article-title":"What happened to patients with obsessive compulsive disorder during the COVID-19 pandemic? A multicentre report from tertiary clinics in northern Italy","author":"Benatti","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib88","doi-asserted-by":"crossref","DOI":"10.1097\/YIC.0000000000000137","article-title":"Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder?","author":"Benatti","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib89","author":"Benatti","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2022.152315","article-title":"The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network","volume":"116","author":"Benatti","year":"2022","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archpsyc.1989.01810010025004","article-title":"Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action","volume":"46","author":"Benkelfat","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib92","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jpsychires.2013.03.022","article-title":"Repetitive Transcranial Magnetic Stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials","volume":"47","author":"Berlim","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib93","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.09m05266gre","article-title":"Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder","author":"Berlin","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib94","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004714-199506000-00009","article-title":"Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine","volume":"15","author":"Berman","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpsychires.2021.02.060","article-title":"First manic\/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review","volume":"137","author":"Bertolin","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib96","first-page":"270","article-title":"[Therapeutic response to plasmapheresis in four cases with obsessive-compulsive disorder and tic disorder triggered by streptococcal infections]","volume":"18","author":"Be\u015firo\u011flu","year":"2007","journal-title":"T\u00fcrk Psikiyatri Derg."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102739","article-title":"Yoga therapy for obsessive compulsive disorder (OCD): A case series from India","volume":"62","author":"Bhat","year":"2021","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib98","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/09540261.2016.1170001","article-title":"Designing and validation of a yoga-based intervention for obsessive compulsive disorder","volume":"28","author":"Bhat","year":"2016","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib10001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104156","article-title":"Effectiveness of add-on yoga in reducing the symptoms of obsessive compulsive disorder (OCD): A randomized controlled trial","volume":"99","author":"Bhat","year":"2024","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib99","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1614.2004.01397.x","article-title":"Late onset OCD","volume":"38","author":"Bhattacharyya","year":"2004","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2009.77","article-title":"Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib101","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291711000742","article-title":"Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective","author":"Bienvenu","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0028-1085439","article-title":"Improvement of Obsessive-compulsive Disorder with Divalproex and Lamotrigine in Two Patients with Bipolar II Disorder","volume":"42","author":"Bisol","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib103","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/da.22898","article-title":"The impact of attention deficit hyperactivity disorder in obsessive-compulsive disorder subjects","volume":"36","author":"Blanco-Vieira","year":"2019","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0447.1988.tb08544.x","article-title":"Lifetime prevalence of psychiatric disorders in Edmonton","volume":"77","author":"Bland","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/mp.2014.50","article-title":"Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorder","volume":"19","author":"Bloch","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib106","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/da.22103","article-title":"Long-term outcome in adults with obsessive-compulsive disorder","volume":"30","author":"Bloch","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib107","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","author":"Bloch","year":"2006","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib108","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib109","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaac.2015.01.011","article-title":"Assessment and management of treatment-refractory obsessive-compulsive disorder in children","volume":"54","author":"Bloch","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2012.05.028","article-title":"Effects of ketamine in treatment-refractory obsessive-compulsive disorder","author":"Bloch","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib111","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/appi.psy.42.4.314","article-title":"Fluoxetine in Pathologic Skin-Picking: Open-Label and Double-Blind Results","volume":"42","author":"Bloch","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib112","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40264-015-0363-z","article-title":"Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case\u2013Control Analysis Using the Clinical Practice Research Datalink","volume":"39","author":"Bloechliger","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib113","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2146\/ajhp060371","article-title":"Pregabalin: an antiepileptic agent useful for neuropathic pain","volume":"64","author":"Blommel","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib114","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(18)30295-2","article-title":"Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial","volume":"391","author":"Blumberger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/16506073.2017.1321683","article-title":"App-guided exposure and response prevention for obsessive compulsive disorder: an open pilot trial","volume":"46","author":"Boisseau","year":"2017","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/104012371202400104","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit\/hyperactivity disorder","volume":"24","author":"Bond","year":"2012","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114752","article-title":"Social cognition and empathy in adults with obsessive compulsive disorder: A meta-analysis","volume":"316","author":"Bora","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib118","article-title":"Twelve-Month Prevalence of and Risk Factors for Suicide Attempts in the World Health Organization World Mental Health Surveys","author":"Borges","year":"2010","journal-title":"Psychiatrist.com"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(89)90385-3","article-title":"Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels","author":"Bormann","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocrd.2015.03.003","article-title":"Biological treatments for obsessive-compulsive and related disorders","volume":"6","author":"Borue","year":"2015","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib121","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brat.2012.01.002","article-title":"Community treatment of severe, refractory obsessive-compulsive disorder","volume":"50","author":"Boschen","year":"2012","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib122","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jbtep.2009.10.006","article-title":"Predicting outcome of treatment for severe, treatment resistant OCD in inpatient and community settings","volume":"41","author":"Boschen","year":"2010","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib123","first-page":"1","article-title":"Effects of exercise on obsessive-compulsive disorder symptoms: a systematic review and meta-analysis","author":"Bottoms","year":"2022","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib124","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2021.152268","article-title":"Short communication: A report of the first twelve months of an early intervention service for obsessive-compulsive disorder (OCD)","volume":"110","author":"Brakoulias","year":"2021","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib126","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/13651501.2017.1374413","article-title":"The Nepean Belief Scale: preliminary reliability and validity in obsessive\u2013compulsive disorder","volume":"22","author":"Brakoulias","year":"2018","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib127","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14656566.2019.1700229","article-title":"Advances in the pharmacological management of obsessive-compulsive disorder in the postpartum period","volume":"21","author":"Brakoulias","year":"2020","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/154733251903100311","article-title":"Suicide ideation and attempts in obsessive-compulsive disorder","volume":"31","author":"Breet","year":"2019","journal-title":"Ann. Clin. Psychiatr. : official journal of the American Academy of Clinical Psychiatrists"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12402-014-0146-x","article-title":"The neurobiological link between OCD and ADHD","volume":"6","author":"Brem","year":"2014","journal-title":"ADHD Attention Deficit and Hyperactivity Disorders"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib130","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/PSY.0000000000000988","article-title":"Lifestyle interventions in the treatment of obsessive-compulsive and related disorders: A systematic review","volume":"83","author":"Brierley","year":"2021","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib132","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1176\/appi.ajp.2018.17121311","article-title":"Maternal immune activation and neuropsychiatric illness: a translational research perspective","volume":"175","author":"Brown","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib133","doi-asserted-by":"crossref","DOI":"10.1177\/0706743716633423","article-title":"Potential for drug-drug interactions with adjunctive tramadol use in treatment of obsessive-compulsive disorder","author":"Brown","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib134","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01.nmd.0000253730.31610.6c","article-title":"A Pilot Study of Moderate-Intensity Aerobic Exercise for Obsessive Compulsive Disorder","volume":"195","author":"Brown","year":"2007","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib135","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/0269881111431751","article-title":"Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study","volume":"26","author":"Bruno","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib136","first-page":"17r02232","article-title":"Antibiotics for PANDAS? Limited evidence: review and putative mechanisms of action","volume":"20","author":"Burchi","year":"2018","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173660","article-title":"D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis","author":"B\u00fcrkner","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib138","doi-asserted-by":"crossref","DOI":"10.1590\/S1516-44462002000500014","article-title":"What happens to anxiety disorders in later life?","author":"Byrne","year":"2002","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib139","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1176\/ps.47.2.170","article-title":"A preliminary study of partial hospital management of severe obsessive-compulsive disorder","volume":"47","author":"Bystritsky","year":"1996","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fpsyt.2019.00557","article-title":"Co-morbid obsessive-compulsive disorder and attention deficit hyperactivity disorder: neurobiological commonalities and treatment implications","volume":"10","author":"Cabarkapa","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib141","doi-asserted-by":"crossref","DOI":"10.1017\/S135246580999066X","article-title":"Group versus individual cognitive treatment for obsessive-compulsive disorder: Changes in severity at post-treatment and one-year follow-up","author":"Cabedo","year":"2010","journal-title":"Behav. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib142","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0005-7916(94)90001-9","article-title":"Treatment of obsessive compulsive disorder in the elderly: a review and case example","volume":"25","author":"Calamari","year":"1994","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib143","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/cap.2016.0105","article-title":"A survey of pediatric acute-onset neuropsychiatric syndrome characteristics and course","volume":"27","author":"Calaprice","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib144","doi-asserted-by":"crossref","DOI":"10.1097\/00005053-199910000-00008","article-title":"Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior","volume":"187","author":"Calvocoressi","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib145","first-page":"1150","article-title":"Inpatient treatment of patients with severe obsessive-compulsive disorder","volume":"44","author":"Calvocoressi","year":"1993","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.05.040","article-title":"A comparison of cluster and factor analytic techniques for identifying symptom-based dimensions of obsessive-compulsive disorder","author":"Cameron","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib147","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.janxdis.2012.06.003","article-title":"The epidemiology of obsessive\u2013compulsive disorder in Spanish school children","volume":"26","author":"Canals","year":"2012","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib148","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jagp.2017.08.015","article-title":"Anxiety disorders in old age: psychiatric comorbidities, quality of life, and prevalence according to age, gender, and country","volume":"26","author":"Canuto","year":"2018","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib149","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40473-016-0066-5","article-title":"Personalizing the treatment of pediatric obsessive-compulsive disorder: Evidence for predictors and moderators of treatment outcomes","volume":"3","author":"Caporino","year":"2016","journal-title":"Curr Behav Neurosci Rep"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/B:MEBR.0000027423.34733.12","article-title":"Single Photon Emission Computed Tomography (SPECT) in Obsessive\u2013Compulsive Disorder Before and After Treatment with Inositol","volume":"19","author":"Carey","year":"2004","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib151","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brs.2017.09.004","article-title":"Clinical and electrophysiological outcomes of deep TMS over the medial prefrontal and anterior cingulate cortices in OCD patients","volume":"11","author":"Carmi","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib152","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1176\/appi.ajp.2019.18101180","article-title":"Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial","volume":"176","author":"Carmi","year":"2019","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib153","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1077-7229(99)80019-4","article-title":"Cognitive behavioral treatment of older adults with obsessive-compulsive disorder","volume":"6","author":"Carmin","year":"1999","journal-title":"Cognit. Behav. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib154","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/da.22728","article-title":"Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials","volume":"35","author":"Carpenter","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib155","first-page":"387","article-title":"Treatment outcome of obsessive compulsive disorder with comorbid social phobia","volume":"53","author":"Carrasco","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib156","first-page":"150","article-title":"The silent geriatric giant: Anxiety disorders in late life","volume":"11","author":"Cassidy","year":"2008","journal-title":"Geriatrics and Aging"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib157","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/YIC.0000000000000342","article-title":"Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology","volume":"36","author":"Castle","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib158","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jpsychires.2005.04.010","article-title":"Obsessive\u2013compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors: OCD follow-up study","volume":"40","author":"Catapano","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib159","doi-asserted-by":"crossref","DOI":"10.1159\/000049282","article-title":"Insight and resistance in patients with obsessive-compulsive disorder","author":"Catapano","year":"2001","journal-title":"Psychopathology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0924-977X(96)00382-3","article-title":"Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment","volume":"7","author":"Cavedini","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib161","series-title":"Obsessional States","first-page":"259","article-title":"Psychotherapy and obsessional disorders","author":"Cawley","year":"1974"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib162","article-title":"Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: A network meta-analysis","author":"Cervin","year":"2023","journal-title":"JCPP (J. Child Psychol. Psychiatry)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib163","first-page":"1","article-title":"Towards a definitive symptom structure of obsessive-compulsive disorder: A factor and network analysis of 87 distinct symptoms in 1366 individuals","author":"Cervin","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib164","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/wps.20984","article-title":"Empirical severity benchmarks for obsessive\u2010compulsive disorder across the lifespan","volume":"21","author":"Cervin","year":"2022","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib166","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.brat.2011.03.006","article-title":"Intensive cognitive-behavioural treatment for women with postnatal obsessive-compulsive disorder: a consecutive case series","volume":"49","author":"Challacombe","year":"2011","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib167","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1017\/S0033291716003573","article-title":"A pilot randomized controlled trial of time-intensive cognitive\u2013behaviour therapy for postpartum obsessive\u2013compulsive disorder: effects on maternal symptoms, mother\u2013infant interactions and attachment","volume":"47","author":"Challacombe","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib168","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3399\/bjgp13X667376","article-title":"A hidden problem: consequences of the misdiagnosis of perinatal obsessive-compulsive disorder","volume":"63","author":"Challacombe","year":"2013","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib169","article-title":"Long-term clinical outcome of a novel bilateral capsulotomy with focused ultrasound in refractory obsessive-compulsive disorder treatment","author":"Chang","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib170","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s10803-018-3703-x","article-title":"A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan\/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism","volume":"50","author":"Chez","year":"2020","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2022.100712","article-title":"Is mindfulness-based intervention an effective treatment for people with obsessive-compulsive disorder? A systematic review and meta-analysis","volume":"32","author":"Chien","year":"2022","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib172","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/appi.psychotherapy.2009.63.3.245","article-title":"Is a psychodynamic perspective relevant to the clinical management of obsessive-compulsive disorder?","volume":"63","author":"Chlebowski","year":"2009","journal-title":"Am. J. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib173","first-page":"279","article-title":"Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder","volume":"26","author":"Chouinard","year":"1990","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib174","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000070837","article-title":"Anterior capsulotomy for treatment of refractory obsessive-compulsive disorder: results in a young and an old patient","volume":"79","author":"Christensen","year":"2002","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib175","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14709","article-title":"Valproate Use During Spermatogenesis and Risk to Offspring","volume":"7","author":"Christensen","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib176","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1176\/ajp.148.11.1566","article-title":"A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania","volume":"148","author":"Christenson","year":"1991","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib177","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1534650108326974","article-title":"Cognitive Behavioral Treatment of Postpartum Onset: Obsessive Compulsive Disorder With Aggressive Obsessions","volume":"8","author":"Christian","year":"2009","journal-title":"Clin. Case Stud."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib178","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/768398","article-title":"High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period","volume":"2009","author":"Cleveland","year":"2009","journal-title":"Neural Plast."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib179","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.52963","article-title":"Glutamatergic Medications for Obsessive-Compulsive and Related Disorders: A Systematic Review and Meta-Analysis","volume":"8","author":"Coelho","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104677","article-title":"The metacontrol hypothesis as diagnostic framework of OCD and ADHD: A dimensional approach based on shared neurobiological vulnerability","volume":"137","author":"Colzato","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib181","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1037\/ccp0000155","article-title":"Internet-delivered, family-based treatment for early-onset OCD: A pilot randomized trial","volume":"85","author":"Comer","year":"2017","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib182","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00004583-200110000-00011","article-title":"Long-Term Sertraline Treatment of Children and Adolescents With Obsessive-Compulsive Disorder","volume":"40","author":"Cook","year":"2001","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib183","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.16030053","article-title":"Refractory OCD due to thalamic infarct with response to dronabinol","author":"Cooper","year":"2017","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial","author":"Coric","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/wps.20881","article-title":"Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review","volume":"20","author":"Correll","year":"2021","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib186","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11101","article-title":"Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder","author":"Costa","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib187","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004850-199001000-00002","article-title":"A Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder","volume":"5","author":"Cottraux","year":"1990","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib188","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000056269","article-title":"A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder","volume":"70","author":"Cottraux","year":"2001","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib189","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10401230490486972","article-title":"A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder","volume":"16","author":"Crockett","year":"2004","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114869","article-title":"Deep brain stimulation in obsessive-compulsive disorder: Results from meta-analysis","volume":"317","author":"Cruz","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib191","article-title":"Social skills in patients with obsessive-compulsive disorder before and after treatment","volume":"46","author":"da Silva","year":"2024","journal-title":"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib192","article-title":"Efficacy and safety of transcranial direct current stimulation as an add-on treatment for obsessive-compulsive disorder: a randomized, sham-controlled trial","author":"Da Silva","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib193","series-title":"Report on two cases and proposal for a randomized, sham-controlled trial","article-title":"Transcranial direct current stimulation for treatment-resistant obsessive-compulsive disorder","author":"Da Silva","year":"2016"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib194","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.07.002","article-title":"Neuropsychological predictors of response to randomized treatment in obsessive-compulsive disorder","volume":"39","author":"D'Alcante","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib195","series-title":"The efficacy of supplementary motor area-repetitive transcranial magnetic stimulation sma rTMS in obsessive compulsive disorder (OCD) in children and adolescents a randomized double blind sham controlled study","author":"Das","year":"2015"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib196","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jnnp-2020-325308","article-title":"Lesional psychiatric neurosurgery: meta-analysis of clinical outcomes using a transdiagnostic approach","volume":"93","author":"Davidson","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib197","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41398-020-01072-1","article-title":"Examining cognitive change in magnetic resonance-guided focused ultrasound capsulotomy for psychiatric illness","volume":"10","author":"Davidson","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib198","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1460-9568.2002.02138.x","article-title":"Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy","volume":"16","author":"Davis","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib199","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-cycloserine on extinction: translation from preclinical to clinical work","volume":"60","author":"Davis","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.jpsychires.2025.12.039_bib200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00003495-199700532-00006","article-title":"Pharmacology of tramadol","volume":"53","author":"Dayer","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib201","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/YIC.0000000000000284","article-title":"Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report","volume":"35","author":"De Berardis","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib202","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/jcm13051230","article-title":"Obsessive\u2013Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review","volume":"13","author":"De Filippis","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib203","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-0447.1997.tb09929.x","article-title":"Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy","volume":"96","author":"De Haan","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib204","first-page":"1371","article-title":"Nonresponse to Treatment for Depression Following Myocardial Infarction: Association With Subsequent Cardiac Events","volume":"164","author":"De Jonge","year":"2007","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/HRP.0b013e318294f5fd","article-title":"The current state of the empirical evidence for psychoanalysis: a meta-analytic approach","volume":"21","author":"de Maat","year":"2013","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib206","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.euroneuro.2012.08.006","article-title":"Trajectory in obsessive-compulsive disorder comorbidities","volume":"23","author":"de Mathis","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib207","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","article-title":"Antidepressants and the risk of hyponatremia: a class-by-class review of literature","volume":"55","author":"De Picker","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib208","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","article-title":"A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants","volume":"44","author":"De Vries","year":"2021","journal-title":"Drug Saf."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib209","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib210","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852900000079","article-title":"Duration of untreated psychosis and duration of untreated illness: new vistas","author":"Dell\u2019osso","year":"2010","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib211","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1742-1241.2006.01167.x","article-title":"Diagnosis and treatment of obsessive-compulsive disorder and related disorders","volume":"61","author":"Dell'Osso","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib212","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852917000177","article-title":"Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)","author":"Dell'Osso","year":"2018","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib213","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.euroneuro.2013.05.004","article-title":"The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)","volume":"23","author":"Dell'Osso","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib214","doi-asserted-by":"crossref","DOI":"10.1080\/13651501.2019.1621348","article-title":"Investigating duration of illness and duration of untreated illness in obsessive compulsive disorder reveals patients remain at length pharmacologically untreated","author":"Dell'Osso","year":"2019","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13651501.2016.1207087","article-title":"Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)","volume":"20","author":"Dell'Osso","year":"2016","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib216","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eurpsy.2017.06.008","article-title":"Obsessive-compulsive disorder in the elderly: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)","volume":"45","author":"Dell'Osso","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib217","doi-asserted-by":"crossref","DOI":"10.3109\/15622970903418544","article-title":"Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder","author":"Dell'Osso","year":"2010","journal-title":"World J. Biol. Psychiatr. : Offici. J. World Federation Soc. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib218","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13651501.2017.1291822","article-title":"Parsing the phenotype of obsessive-compulsive tic disorder (OCTD): a multidisciplinary consensus","volume":"21","author":"Dell'Osso","year":"2017","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib219","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0269881107079865","article-title":"Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series","volume":"22","author":"Dell\u2019osso","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib220","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852915000565","article-title":"Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)","author":"Dell'Osso","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib221","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1092852919001068","article-title":"Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)","volume":"25","author":"Dell'Osso","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib222","doi-asserted-by":"crossref","DOI":"10.1038\/sj.mp.4001728","article-title":"Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive-compulsive disorder","author":"Delorme","year":"2005","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib223","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13052-021-01177-3","article-title":"Psychoeducation focused on family accommodation: a practical intervention for parents of children and adolescents with obsessive-compulsive disorder","volume":"47","author":"Demaria","year":"2021","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib224","first-page":"272","article-title":"Randomized controlled trial of adjunctive EEG-biofeedback treatment of obsessive-compulsive disorder","volume":"26","author":"Deng","year":"2014","journal-title":"Shanghai Arch Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2019.19060656","article-title":"Efficacy of deep brain stimulation of the ventral anterior limb of the internal capsule for refractory obsessive-compulsive disorder: A clinical cohort of 70 patients","volume":"177","author":"Denys","year":"2020","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib226","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.jcp.0000095342.32154.54","article-title":"A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib227","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v65n0106","article-title":"A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib228","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/16506073.2015.1005660","article-title":"Efficacy of technology-delivered cognitive behavioural therapy for OCD versus control conditions, and in comparison with therapist-administered CBT: meta-analysis of randomized controlled trials","volume":"44","author":"D\u00e8ttore","year":"2015","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib229","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archpsyc.1991.01810320054008","article-title":"Clomipramine in the treatment of patients with obsessive-compulsive disorder","volume":"48","author":"DeVeaugh-Geiss","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/medicina57010009","article-title":"Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder","volume":"57","author":"Di Salvo","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib231","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0269881108099423","article-title":"Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial","volume":"24","author":"Diniz","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.npbr.2016.08.003","article-title":"Treatment-resistant obsessive-compulsive disorder: Insights from an open trial of transcranial direct current stimulation (tDCS) to design a RCT","author":"Dinn","year":"2016","journal-title":"Neurol. Psychiatr. Brain Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib233","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.psychres.2010.10.031","article-title":"Cognitive Assessment Instrument of Obsessions and Compulsions (CAIOC-13) - a new 13-item scale for evaluating functional impairment associated with OCD","volume":"187","author":"Dittrich","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib234","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0447.2006.00770.x","article-title":"Prevalence and predictors of depression in populations of elderly: a review","volume":"113","author":"Djernes","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajmg.b.30149","article-title":"A family study of early-onset obsessive-compulsive disorder","volume":"136B","author":"do Rosario-Campos","year":"2005","journal-title":"Am. J. Med. Genet B Neuropsychiatr. Genet."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib236","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.649833","article-title":"Case report: treatment of a comorbid attention deficit hyperactivity disorder and obsessive-compulsive disorder with psychostimulants","volume":"12","author":"Dogan-Sander","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyg.2021.697717","article-title":"Associations of Autism Traits With Obsessive Compulsive Symptoms and Well-Being in Patients With Obsessive Compulsive Disorder: A Cross-Sectional Study","volume":"12","author":"Doi","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib238","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib239","doi-asserted-by":"crossref","DOI":"10.1017\/S1461145712000740","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials","author":"Dold","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jad.2019.06.018","article-title":"Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: Prevalence and predictors","volume":"256","author":"Domingues-Castro","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib241","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpsychires.2021.06.035","article-title":"Comorbid obsessive-compulsive disorder in individuals with eating disorders: An epidemiological meta-analysis","volume":"141","author":"Drakes","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib242","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.genhosppsych.2012.02.001","article-title":"Physical complications of severe, chronic obsessive-compulsive disorder: a comparison with general psychiatric inpatients","volume":"34","author":"Drummond","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib243","doi-asserted-by":"crossref","DOI":"10.1002\/da.22578","article-title":"Transcranial direct current stimulation for obsessive-compulsive disorder: A randomized, controlled, partial crossover trial","author":"D'Urso","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib244","article-title":"Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder","author":"D'Urso","year":"2015","journal-title":"Neurocase"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113784","article-title":"Efficacy of intensive orbitofrontal continuous theta burst stimulation (iOFcTBS) in obsessive compulsive disorder: A randomized placebo controlled study","volume":"298","author":"Dutta","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib246","doi-asserted-by":"crossref","first-page":"96","DOI":"10.64719\/pb.4398","article-title":"Lamotrigine and Stevens-Johnson Syndrome Prevention","volume":"51","author":"Edinoff","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib247","doi-asserted-by":"crossref","DOI":"10.1521\/pedi.2006.20.3.294","article-title":"Clarifying the convergence between obsessive compulsive personality disorder criteria and obsessive compulsive disorder","author":"Eisen","year":"2006","journal-title":"J. Pers. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib248","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4088\/JCP.v60n0514","article-title":"Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study","volume":"60","author":"Eisen","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib249","first-page":"102","article-title":"The Brown Assessment of Beliefs Scale: Reliability and Validity","volume":"155","author":"Eisen","year":"1998","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib250","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4088\/JCP.08m04806blu","article-title":"A 2-year prospective follow-up study of the course of obsessive-compulsive disorder","volume":"71","author":"Eisen","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib251","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/comp.2001.27898","article-title":"Insight and treatment outcome in obsessive-compulsive disorder","volume":"42","author":"Eisen","year":"2001","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib252","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.12m07657","article-title":"Five-year course of obsessive-compulsive disorder: predictors of remission and relapse","author":"Eisen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib253","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(86)90325-6","article-title":"Buspirone: review of its pharmacology and current perspectives on its mechanism of action","volume":"80","author":"Eison","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib254","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.psychres.2016.02.031","article-title":"Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorders: Double blind randomized clinical trial","volume":"238","author":"Elbeh","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib255","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijerph21050551","article-title":"Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression","volume":"21","author":"Eleftheriou","year":"2024","journal-title":"IJERPH"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib256","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00228-020-03049-x","article-title":"Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany","volume":"77","author":"Elsayed","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib257","doi-asserted-by":"crossref","DOI":"10.1097\/YIC.0000000000000098","article-title":"Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial","author":"Emadi-Kouchak","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib258","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/pcn.12394","article-title":"Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study","volume":"70","author":"Emamzadehfard","year":"2016","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib259","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.156.1.55","article-title":"Marital Adjustment and Obsessive\u2013Compulsive Disorder","volume":"156","author":"Emmelkamp","year":"1990","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib260","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/cap.2014.0128","article-title":"A Promising Preliminary Study of Aripiprazole for Treatment-Resistant Childhood Obsessive-Compulsive Disorder","volume":"25","author":"Ercan","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib261","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00004714-200110000-00006","article-title":"Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder","volume":"21","author":"Erzegovesi","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib262","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/pcn.12430","article-title":"Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial","volume":"70","author":"Esalatmanesh","year":"2016","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib263","first-page":"154","article-title":"Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial","volume":"12","author":"Esalatmanesh","year":"2017","journal-title":"Iran. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib264","series-title":"Valproate and related substances - referral (European Commision Final Decision)","year":"2018"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib266","doi-asserted-by":"crossref","DOI":"10.1192\/apt.bp.106.003020","article-title":"Cognitive\u2013behavioural therapy with older people","author":"Evans","year":"2007","journal-title":"Adv. Psychiatr. Treat."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib267","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13398","article-title":"High prevalence and incidence of obsessive-compulsive disorder among women across pregnancy and the postpartum","volume":"82","author":"Fairbrother","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib268","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/jnp.4.1.70","article-title":"Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder","volume":"4","author":"Fallon","year":"1992","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib269","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.55.10.918","article-title":"Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study","author":"Fallon","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005053-199303000-00007","article-title":"A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder","volume":"181","author":"Fals-Stewart","year":"1993","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib271","article-title":"Systematic review and meta-analysis: An empirical approach to defining treatment response and remission in pediatric obsessive-compulsive disorder","author":"Farhat","year":"2021","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib272","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2018.07.008","article-title":"Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial","volume":"104","author":"Farnia","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib273","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jad.2020.01.144","article-title":"Clinical expression and treatment response among children with comorbid obsessive compulsive disorder and attention-deficit\/hyperactivity disorder","volume":"266","author":"Farrell","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib274","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.brat.2010.01.004","article-title":"Cognitive\u2013behavioral treatment of childhood obsessive\u2013compulsive disorder in community-based clinical practice: clinical significance and benchmarking against efficacy","volume":"48","author":"Farrell","year":"2010","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.psychres.2012.04.035","article-title":"Comorbidity and treatment response in pediatric obsessive-compulsive disorder: A pilot study of group cognitive-behavioral treatment","volume":"199","author":"Farrell","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib276","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/da.23242","article-title":"Efficacy of D\u2010cycloserine augmented brief intensive cognitive\u2010behavioural therapy for paediatric obsessive\u2010compulsive disorder: A randomised clinical trial","volume":"39","author":"Farrell","year":"2022","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib277","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.janxdis.2018.07.002","article-title":"Adaptive treatment strategies for children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple assignment randomized trial","volume":"58","author":"Fatori","year":"2018","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib278","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13085","article-title":"Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide","volume":"81","author":"Fawcett","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib279","article-title":"Time-related predictors of suicide in major affective disorder","author":"Fawcett","year":"1990","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpsychires.2016.05.015","article-title":"Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study","volume":"80","author":"Feng","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib281","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jad.2019.11.136","article-title":"Comorbidity of obsessive-compulsive disorder in bipolar spectrum disorders: Systematic review and meta-analysis of its prevalence","volume":"263","author":"Ferentinos","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib282","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/mp.2016.115","article-title":"Suicide in obsessive\u2013compulsive disorder: a population-based study of 36 788 Swedish patients","volume":"22","author":"Fern\u00e1ndez de la Cruz","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib283","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jad.2006.04.019","article-title":"Clinical features associated to refractory obsessive-compulsive disorder","volume":"94","author":"Ferrao","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib284","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/YIC.0000000000000237","volume":"33","author":"Fineberg","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib285","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152371","article-title":"Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): A randomised controlled crossover trial","volume":"122","author":"Fineberg","year":"2023","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib286","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.euroneuro.2019.02.002","article-title":"Early intervention for obsessive compulsive disorder: An expert consensus statement","volume":"29","author":"Fineberg","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib287","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/13651501.2012.755206","article-title":"A prospective population-based cohort study of the prevalence, incidence and impact of obsessive-compulsive symptomatology","volume":"17","author":"Fineberg","year":"2013","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib288","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib289","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13651500500307180","article-title":"Group cognitive behaviour therapy in obsessive-compulsive disorder (OCD): a controlled study","volume":"9","author":"Fineberg","year":"2005","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib290","doi-asserted-by":"crossref","DOI":"10.1590\/1516-4446-2013-1282","article-title":"Obsessive-compulsive (anankastic) personality disorder: toward the ICD-11 classification","author":"Fineberg","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib291","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.psychres.2014.12.003","article-title":"Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults","volume":"227","author":"Fineberg","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib292","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S1092852900015340","article-title":"Does Obsessive-Compulsive Personality Disorder Belong Within the Obsessive-Compulsive Spectrum?","volume":"12","author":"Fineberg","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib293","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.euroneuro.2006.11.005","article-title":"Escitalopram prevents relapse of obsessive-compulsive disorder","volume":"17","author":"Fineberg","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib294","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jbtep.2006.12.001","article-title":"Metacognitive therapy for obsessive\u2013compulsive disorder: A case series","volume":"39","author":"Fisher","year":"2008","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib295","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jad.2022.01.048","article-title":"Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise\/network meta-analysis","volume":"302","author":"Fitzsimmons","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib296","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archpsyc.1985.01790330057007","article-title":"Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study","volume":"42","author":"Flament","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib297","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00004583-198811000-00018","article-title":"Obsessive compulsive disorder in adolescence: an epidemiological study","volume":"27","author":"Flament","year":"1988","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib298","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/ajp.151.5.640","article-title":"Epidemiology and comorbidity of anxiety disorders in the elderly","volume":"151","author":"Flint","year":"1994","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib299","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1037\/1040-3590.14.4.485","article-title":"The Obsessive-Compulsive Inventory: development and validation of a short version","volume":"14","author":"Foa","year":"2002","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib300","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib301","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamapsychiatry.2021.3997","article-title":"Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure\/Response Prevention Augmentation: A Randomized Clinical Trial","volume":"79","author":"Foa","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib302","series-title":"Exposure and Response (Ritual) Prevention for Obsessive Compulsive Disorder: Therapist Guide","author":"Foa","year":"2012"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib303","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4088\/JCP.14r09129","article-title":"Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review","volume":"76","author":"Fontenelle","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib304","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3956(02)00087-0","article-title":"Early- and late-onset obsessive-compulsive disorder in adult patients: an exploratory clinical and therapeutic study","volume":"37","author":"Fontenelle","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib305","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jad.2023.06.068","article-title":"Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials","volume":"338","author":"Fornaro","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib306","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1037\/0022-006X.68.4.594","article-title":"Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples","volume":"68","author":"Franklin","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib307","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2014.170","article-title":"Family-based treatment of early childhood obsessive-compulsive disorder: The pediatric obsessive-compulsive disorder treatment study for young children (POTS Jr)\u2014A randomized clinical trial","author":"Freeman","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib308","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/0022-006X.65.3.405","article-title":"Cognitive-behavioral treatment of obsessive thoughts: a controlled study","volume":"65","author":"Freeston","year":"1997","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib309","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-981-32-9705-0_18","article-title":"Neurostimulation in anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder","volume":"1191","author":"Freire","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib310","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbi.2017.12.004","article-title":"Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum","volume":"69","author":"Frick","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib311","first-page":"329","article-title":"Obsessions and Compulsions in the Community: Prevalence, Interference, Help-Seeking, Developmental Stability, and Co-Occurring Psychiatric Conditions","volume":"166","author":"Fullana","year":"2009","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib312","first-page":"150","article-title":"Retrospective Review of Fluvoxamine-Clomipramine Combination Therapy in Obsessive-Compulsive Disorder in Children and Adolescents","volume":"30","author":"Fung","year":"2021","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib313","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S2215-0366(19)30217-2","article-title":"Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis","volume":"6","author":"Furukawa","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib314","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/acps.12275","article-title":"Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis","volume":"130","author":"Furukawa","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib315","doi-asserted-by":"crossref","DOI":"10.1017\/S1461145799001546","article-title":"Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: a double-blind cross-over study","author":"Fux","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib316","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3956(03)00077-3","article-title":"A placebo-controlled cross-over trial of adjunctive EPA in OCD","volume":"38","author":"Fux","year":"2004","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib317","article-title":"Inositol treatment of obsessive-compulsive disorder","author":"Fux","year":"1996","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib318","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/07351692109348932","article-title":"Psychoanalytically Informed Approaches to the Treatment of Obsessive-Compulsive Disorder","volume":"21","author":"Gabbard","year":"2001","journal-title":"Psychoanal. Inq."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib319","first-page":"39","article-title":"Escitalopram treatment of trichotillomania","volume":"22","author":"Gadde","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib320","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/jnnp-2021-328738","article-title":"Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis","volume":"93","author":"Gadot","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib321","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaac.2010.06.013","article-title":"Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I)","volume":"49","author":"Garcia","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib322","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2014.07.009","article-title":"Factors associated with non-treatment or delayed treatment seeking in OCD sufferers: a review of the literature","author":"Garc\u00eda-Soriano","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib323","series-title":"Handbook of Psychotherapy and Behavior Change","article-title":"Research on Client Variables in Psychotherapy","author":"Garfield","year":"1994"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib324","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.biopsych.2024.02.110","article-title":"Changes in Frontoamygdala Circuitry Associated With a Parent-Focused Intervention for Pediatric Anxiety Disorders","volume":"95","author":"Gee","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00004583-200201000-00011","article-title":"Attention-deficit\/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact?","volume":"41","author":"Geller","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib326","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1520-6394(2000)11:4<163::AID-DA3>3.0.CO;2-3","article-title":"Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings","volume":"11","author":"Geller","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib327","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/104454603322126313","article-title":"Impact of Comorbidity on Treatment Response to Paroxetine in Pediatric Obsessive-Compulsive Disorder: Is the Use of Exclusion Criteria Empirically Supported in Randomized Clinical Trials?","volume":"13","author":"Geller","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib328","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1176\/appi.ajp.160.11.1919","article-title":"Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive compulsive disorder","volume":"160","author":"Geller","year":"2003","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib329","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.678538","article-title":"Developmental considerations in obsessive compulsive disorder: Comparing pediatric and adult-onset cases","author":"Geller","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib330","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder","volume":"51","author":"Geller","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib331","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/JCP.0b013e31822bb1ff","article-title":"Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: A systematic appraisal","volume":"31","author":"Gentile","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib332","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11920-019-1062-8","article-title":"Obsessive-compulsive disorder: autoimmunity and neuroinflammation","volume":"21","author":"Gerentes","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib333","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1891\/0889-8391.33.3.174","article-title":"Exposure and Response Prevention for Postpartum Obsessive-Compulsive Disorder","volume":"33","author":"Gershkovich","year":"2019","journal-title":"J. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib334","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.beth.2020.05.001","article-title":"Integrating exposure and response prevention with a mobile app to treat obsessive-compulsive disorder: Feasibility, acceptability, and preliminary effects","volume":"52","author":"Gershkovich","year":"2021","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib335","first-page":"852","article-title":"Comorbid Posttraumatic Stress Disorder: Impact on Treatment Outcome for Obsessive-Compulsive Disorder","volume":"159","author":"Gershuny","year":"2002","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib336","first-page":"134","article-title":"Efficacy of N-acetylcysteine augmentation on obsessive compulsive disorder: A multicenter randomized double blind placebo controlled clinical trial","volume":"12","author":"Ghanizadeh","year":"2017","journal-title":"Iran. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib337","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2009.04.028","article-title":"Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation","volume":"219","author":"Giacobbe","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib338","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2018.04.035","article-title":"A pediatric neurology perspective on pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection and pediatric acute-onset neuropsychiatric syndrome","volume":"199","author":"Gilbert","year":"2018","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib339","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/07317107.2011.571130","article-title":"Treatment of Obsessive Compulsive Disorder in Young Children: An Intervention Model and Case Series","volume":"33","author":"Ginsburg","year":"2011","journal-title":"Child Fam. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib340","doi-asserted-by":"crossref","DOI":"10.1097\/CHI.0b013e3181799ebd","article-title":"Predictors of treatment response in pediatric obsessive-compulsive disorder","author":"Ginsburg","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib341","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2024.02.009","article-title":"Early-onset obsessive-compulsive disorder: Sociodemographic and clinical characterization of a large outpatient cohort","volume":"172","author":"Girone","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib342","series-title":"Paroxetine versus clomipramine and placebo in the treatment of obsessive-compulsive disorder","year":"2008"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib343","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4088\/JCP.v69n1202","article-title":"Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients","volume":"69","author":"Glick","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib344","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/eat.10096","article-title":"Comorbidity between eating disorders and anxiety disorders: a review","volume":"32","author":"Godart","year":"2002","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jad.2015.06.047","article-title":"Predictive value of familiality, stressful life events and gender on the course of obsessive-compulsive disorder","volume":"185","author":"Goldberg","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib346","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.156.4.660a","article-title":"Rapid remission of OCD with tramadol hydrochloride","author":"Goldsmith","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib347","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1176\/appi.neuropsych.11100242","article-title":"A randomized, double-blind trial of repetitive transcranial magnetic stimulation in obsessive-compulsive disorder with three-month follow-up","volume":"24","author":"Gomes","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib348","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000500137","article-title":"The suitability of different subtypes and dimensions of obsessive-compulsive disorder for treatment with anterior capsulotomy: A long-term follow-up study","volume":"97","author":"Gong","year":"2019","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib349","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-199603000-00003","article-title":"Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial","volume":"11","author":"Goodman","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib350","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1989.01810010038006","article-title":"Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib351","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown Obsessive Compulsive Scale. II. Validity","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib352","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib353","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/nn.4419","article-title":"On being a circuit psychiatrist","volume":"19","author":"Gordon","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib354","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jad.2021.12.089","article-title":"Effectiveness and safety of deep brain stimulation for patients with refractory obsessive compulsive disorder and comorbid autism spectrum disorder; A case series","volume":"299","author":"Graat","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib355","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2020.08.018","article-title":"Long-term outcome of deep brain stimulation of the ventral part of the anterior limb of the internal capsule in a cohort of 50 patients with treatment-refractory obsessive-compulsive disorder","volume":"90","author":"Graat","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib356","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0006-3223(01)01074-5","article-title":"The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: The Hopkins OCD family study","volume":"50","author":"Grados","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib357","article-title":"Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder","author":"Grady","year":"1993","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib358","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2016.0060","article-title":"N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib359","first-page":"348","article-title":"Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder","volume":"180","author":"Grant","year":"2023","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib360","doi-asserted-by":"crossref","DOI":"10.1097\/YIC.0000000000000368","article-title":"Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial","author":"Grant","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib361","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psychres.2006.09.015","article-title":"Late-onset obsessive compulsive disorder: clinical characteristics and psychiatric comorbidity","volume":"152","author":"Grant","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib362","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0000000000000327","article-title":"Silymarin Treatment of Obsessive-Compulsive Spectrum Disorders","volume":"35","author":"Grant","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib363","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania: A Double-blind, Placebo-Controlled Study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib364","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/npp.2013.343","article-title":"12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive\u2013Compulsive Disorder","volume":"39","author":"Grant","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib365","doi-asserted-by":"crossref","DOI":"10.1089\/cap.2007.0021","article-title":"An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder","author":"Grant","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib366","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852921000122","article-title":"Early onset obsessive-compulsive disorder: the biological and clinical phenotype","author":"Grassi","year":"2021","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib367","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/JEP.S255375","article-title":"Investigational and experimental drugs to treat obsessive-compulsive disorder","volume":"12","author":"Grassi","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib368","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpsychires.2016.09.012","article-title":"Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation","volume":"83","author":"Grassi","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib369","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S1092852913000795","article-title":"Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics","volume":"19","author":"Grassi","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib370","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.54.1.142","article-title":"Altered cortical excitability in obsessive-compulsive disorder","author":"Greenberg","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib371","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpsychires.2008.10.007","article-title":"Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults","volume":"43","author":"Greenberg","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib372","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2019.102151","article-title":"Cost-effectiveness of treatment alternatives for treatment-refractory pediatric obsessive-compulsive disorder","volume":"69","author":"Gregory","year":"2020","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib373","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1995.03950160039008","article-title":"Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder","volume":"52","author":"Greist","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib374","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004850-199506000-00001","article-title":"A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder","volume":"10","author":"Greist","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib375","first-page":"292","article-title":"Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients","volume":"51","author":"Greist","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib376","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.v63n0209","article-title":"Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control","volume":"63","author":"Greist","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib377","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.janxdis.2009.04.005","article-title":"Prevalence and correlates of obsessive\u2013compulsive disorder among older adults living in the community","volume":"23","author":"Grenier","year":"2009","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib378","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.4088\/JCP.12r07966","article-title":"Antidepressant Exposure During Pregnancy and Congenital Malformations: Is There an Association?: A Systematic Review and Meta-Analysis of the Best Evidence","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.12.039_bib379","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psychres.2009.01.028","article-title":"Socioemotional deficits associated with obsessive\u2013compulsive symptomatology","volume":"175","author":"Grisham","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib380","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/15346501221091273","article-title":"ACT-Informed Treatment of Co-morbid Psychiatric Disorders in the Postpartum Period: A Case Report","volume":"22","author":"Grove","year":"2023","journal-title":"Clin. Case Stud."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib381","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/neu.2018.27","article-title":"Obsessive\u2013compulsive symptoms in schizophrenia: a review","volume":"31","author":"Grover","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib382","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.psychres.2017.10.006","article-title":"Factor analysis of symptom profile in early onset and late onset OCD","volume":"262","author":"Grover","year":"2018","journal-title":"Psychiatry Res. Apr"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib383","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2017.03.001","article-title":"Effects of D-cycloserine augmentation on cognitive behavioral therapy in patients with obsessive-compulsive disorder: A systematic review and meta-analysis","author":"Gu","year":"2017","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib384","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2020.3650","article-title":"Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: A systematic review and meta-analysis","volume":"78","author":"Guidi","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib386","first-page":"218","article-title":"Clinical global impressions. ECDEU assessment manual for psychopharmacology - Revised. US Department of Heath","author":"Guy","year":"1976","journal-title":"Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib387","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib388","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2018.07.001","article-title":"CBT-Plus: A meta-analysis of cognitive behavioral therapy augmentation strategies for obsessive-compulsive disorder","author":"Guzick","year":"2018","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib389","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40360-021-00534-6","article-title":"Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis","volume":"22","author":"Hadi","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib390","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/acps.13276","article-title":"Deep brain stimulation versus ablative surgery for treatment-refractory obsessive-compulsive disorder: A meta-analysis","volume":"143","author":"Hageman","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib391","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-013-3067-z","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)","author":"Haghighi","year":"2013","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib392","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpsychires.2015.06.020","article-title":"Repetitive Transcranial Magnetic Stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD--Results from a single-blind, randomized clinical trial with sham cross-over condition","volume":"68","author":"Haghighi","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib393","article-title":"Long-Term Safety and Efficacy of Focused Ultrasound Capsulotomy for Obsessive-Compulsive Disorder and Major Depressive Disorder","volume":"S0006322324015488","author":"Hamani","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib394","first-page":"6","article-title":"Transcutaneous electrical nerve stimulation for treatment of spinal spasticity","volume":"107","author":"Han","year":"1994","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib395","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fpsyg.2018.00639","article-title":"The Bergen 4-Day OCD Treatment Delivered in a Group Setting: 12-Month Follow-Up","volume":"9","author":"Hansen","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib396","first-page":"273","article-title":"Clomipramine in Combination with Fluvoxamine: A Potent Medication Combination for Severe or Refractory Pediatric OCD","volume":"30","author":"Hardy","year":"2021","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib397","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1648","article-title":"Treating refractory obsessive\u2013compulsive disorder with transcranial direct current stimulation: An open label study","author":"Harika\u2010Germaneau","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib398","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.brs.2019.07.019","article-title":"Continuous theta burst stimulation over the supplementary motor area in refractory obsessive-compulsive disorder treatment: A randomized sham-controlled trial","volume":"12","author":"Harika-Germaneau","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib399","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1037\/abn0000793","article-title":"Top-down and bottom-up contributions to memory performance in OCD: A multilevel meta-analysis with clinical implications","volume":"132","author":"Harkin","year":"2023","journal-title":"J. Psychopathol. Clin. Sci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib400","first-page":"174","article-title":"Attitudes of psychiatry residents in Canadian universities toward neuroscience and its implication in psychiatric practice","volume":"65","author":"Hassan","year":"2020","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib401","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2016.04.010","article-title":"Randomized-controlled trial on a novel (meta-) cognitive self-help approach for obsessive-compulsive disorder (\u201cmyMCT\u201d)","author":"Hauschildt","year":"2016","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib402","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/ijms17030420","article-title":"Transcranial magnetic stimulation of the supplementary motor area in the treatment of obsessive-compulsive disorder: A multi-site study","volume":"17","author":"Hawken","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib403","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2020.103757","article-title":"Technology supported mindfulness for obsessive compulsive disorder: Self-reported mindfulness and EEG correlates of mind wandering","volume":"136","author":"Hawley","year":"2021","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib404","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S2215-0366(22)00232-2","article-title":"Assessment of suicide risk in mental health practice: shifting from prediction to therapeutic assessment, formulation, and risk management","volume":"9","author":"Hawton","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib405","doi-asserted-by":"crossref","DOI":"10.1097\/YCT.0000000000000309","article-title":"Response to transcranial direct current stimulation in a case of episodic obsessive compulsive disorder","author":"Hazari","year":"2016","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib406","series-title":"Health Product InfoWatch","year":"2017"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib407","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YIC.0000000000000043","article-title":"Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder","volume":"29","author":"Heidari","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib408","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-022-00908-2","article-title":"Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden","volume":"36","author":"Heinonen","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib409","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/cap.2005.15.682","article-title":"A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders","volume":"15","author":"Hellings","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib410","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1523\/JNEUROSCI.2618-20.2021","article-title":"Inflammation-induced histamine impairs the capacity of escitalopram to increase hippocampal extracellular serotonin","volume":"41","author":"Hersey","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib411","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0033-3182(97)71446-4","article-title":"Recurrent obsessive-compulsive disorder associated with pregnancy and childbirth","volume":"38","author":"Hertzberg","year":"1997","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib412","article-title":"Memantine as an Augmenting Agent for Severe Pediatric OCD","volume":"166","author":"Hezel","year":"2009","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib413","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder: Advances in diagnosis and treatment","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib414","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archpsyc.57.1.76","article-title":"Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders","volume":"57","author":"Hoehn-Saric","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib415","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4088\/JCP.v69n0415","article-title":"Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials","volume":"69","author":"Hofmann","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib416","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jad.2013.03.014","article-title":"Clinical relevance of comorbidity in obsessive compulsive disorder: the Netherlands OCD Association study","volume":"150","author":"Hofmeijer-Sevink","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib417","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaac.2017.09.002","article-title":"One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder","volume":"56","author":"H\u00f8jgaard","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib418","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00787-019-01276-x","article-title":"Hoarding in children and adolescents with obsessive-compulsive disorder: prevalence, clinical correlates, and cognitive behavioral therapy outcome","volume":"28","author":"H\u00f8jgaard","year":"2019","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib419","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archpsyc.56.11.1033","article-title":"Clomipramine vs Desipramine Crossover Trial in Body Dysmorphic Disorder: Selective Efficacy of a Serotonin Reuptake Inhibitor in Imagined Ugliness","volume":"56","author":"Hollander","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib420","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4088\/JCP.v64n0919","article-title":"Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine","volume":"64","author":"Hollander","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib421","first-page":"498","article-title":"Oxytocin Increases Retention of Social Cognition in Autism","volume":"61","author":"Hollander","year":"2007","journal-title":"Biological Psychiatry, Advances in Understanding and Treating Autism Spectrum Disorders"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib422","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/npp.2009.202","article-title":"Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders","volume":"35","author":"Hollander","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib423","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","article-title":"A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders","volume":"169","author":"Hollander","year":"2012","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib424","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v64n0508","article-title":"Venlafaxine in treatment-resistant obsessive-compulsive disorder","author":"Hollander","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib425","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/15622970309167908","article-title":"A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder","volume":"4","author":"Hollander","year":"2003","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib426","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4088\/JCP.v64n0604","article-title":"A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder","volume":"64","author":"Hollander","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib427","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and asperger's disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib429","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S1461145705005791","article-title":"Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder","volume":"9","author":"Hollander","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib430","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/15622975.2018.1523561","article-title":"Randomized crossover feasibility trial of helminthic Trichuris suis ova versus placebo for repetitive behaviors in adult autism spectrum disorder","volume":"21","author":"Hollander","year":"2020","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib431","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.989550","article-title":"Internet-based cognitive behavioral therapy in children and adolescents with obsessive-compulsive disorder: A randomized controlled trial","volume":"13","author":"Hollmann","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib432","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1192\/bjp.152.4.516","article-title":"A Decision Model in the Treatment of Obsessive\u2013Compulsive Neuroses","volume":"152","author":"Hoogduin","year":"1988","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib433","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12888-021-03272-5","article-title":"Low intensity technology-delivered cognitive behavioral therapy for obsessive-compulsive disorder: a meta-analysis","volume":"21","author":"Hoppen","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib434","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hr\u00f3bjartsson","year":"2013","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib435","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12916-015-0444-y","article-title":"Unaddressed privacy risks in accredited health and wellness apps: a cross-sectional systematic assessment","volume":"13","author":"Huckvale","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib436","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2542","article-title":"Assessment of the data sharing and privacy practices of smartphone apps for depression and smoking cessation","volume":"2","author":"Huckvale","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib437","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib438","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1038\/s41380-024-02638-x","article-title":"Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review","volume":"29","author":"Huneke","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-020-02531-1","article-title":"The effect of dialectical behaviour therapy in autism spectrum patients with suicidality and\/or self-destructive behaviour (DIASS): Study protocol for a multicentre randomised controlled trial","volume":"20","author":"Huntjens","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/da.20506","article-title":"Quality of life and functional impairment in obsessive\u2013compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls","volume":"26","author":"Huppert","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib441","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpsychires.2006.05.007","article-title":"Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder","volume":"41","author":"Husted","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib442","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib443","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10578-017-0724-1","article-title":"An Initial Case Series of Intensive Cognitive\u2013Behavioral Therapy for Obsessive\u2013Compulsive Disorder in Adolescents with Autism Spectrum Disorder","volume":"49","author":"Iniesta-Sep\u00falveda","year":"2018","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib444","doi-asserted-by":"crossref","DOI":"10.1007\/BF00436159","article-title":"D-amphetamine in obsessive-compulsive disorder","author":"Insel","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib446","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/cap.2024.0127","article-title":"Ketamine Treatment for Pediatric Refractory Obsessive: Five Open Label Cases","volume":"35","author":"Ishimuro","year":"2025","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib447","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.4088\/JCP.14r09758","article-title":"Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis","volume":"77","author":"Issari","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib448","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2015.01.015","article-title":"The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis","author":"Ivarsson","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib449","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.comppsych.2014.03.011","article-title":"Predictors of quality of life and functional impairment in obsessive\u2013compulsive disorder","volume":"55","author":"Jacoby","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctim.2016.03.018","article-title":"Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial","volume":"27","author":"Jahanbakhsh","year":"2016","journal-title":"Compl. Ther. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib451","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000446287","article-title":"Repetitive transcranial magnetic stimulation improved symptoms of obsessive-compulsive disorder, but also cognitive performance: Results from a randomized clinical trial with a cross-over design and sham condition","volume":"73","author":"Jahangard","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib452","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/da.22013","article-title":"Clinical predictors of long-term outcome in obsessive-compulsive disorder","volume":"30","author":"Jakubovski","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib453","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2011.05.012","article-title":"Dimensional correlates of poor insight in obsessive-compulsive disorder","author":"Jakubovski","year":"2011","journal-title":"Progress neuro-Psychopharmacol. Biological Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib454","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fpsyt.2020.00118","article-title":"Social Cognition and Obsessive-Compulsive Disorder: A Review of Subdomains of Social Functioning","volume":"11","author":"Jansen","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib455","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10578-020-01066-6","article-title":"An Evaluation of a New Autism-Adapted Cognitive Behaviour Therapy Manual for Adolescents with Obsessive\u2013Compulsive Disorder","volume":"52","author":"Jassi","year":"2021","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib456","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PRA.0000000000000463","article-title":"Obsessive-compulsive disorder in older adults: A comprehensive literature review","volume":"26","author":"Jazi","year":"2020","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib457","article-title":"A case of obsessive-compulsive disorder with fear of contamination of percutaneous endoscopic gastrostomy tube","volume":"18","author":"Jazi","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib458","first-page":"13","article-title":"Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder","volume":"52","author":"Jenike","year":"1991","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib459","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1176\/ajp.154.9.1261","article-title":"Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder","volume":"154","author":"Jenike","year":"1997","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib460","first-page":"923","article-title":"Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo","volume":"147","author":"Jenike","year":"1990","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib461","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1176\/ajp.146.10.1328","article-title":"Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients","volume":"146","author":"Jenike","year":"1989","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib462","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/ajp.147.9.1209","article-title":"A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory","volume":"147","author":"Jenike","year":"1990","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib463","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jad.2017.08.012","article-title":"Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates","volume":"225","author":"Jeon","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib464","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/1817-1745.199461","article-title":"Methylphenidate-induced obsessive-compulsive symptoms: A case report and review of literature","volume":"11","author":"Jhanda","year":"2016","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib465","doi-asserted-by":"crossref","DOI":"10.1007\/s10578-017-0717-0","article-title":"Restricted, Repetitive Behaviors in Autism Spectrum Disorder and Obsessive\u2013Compulsive Disorder: A Comparative Review","volume":"48","author":"Jiujias","year":"2017","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib466","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004714-199108000-00003","article-title":"Acute psychostimulant challenge in primary obsessive-compulsive disorder","volume":"11","author":"Joffe","year":"1991","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib467","doi-asserted-by":"crossref","DOI":"10.1002\/da.22978","article-title":"A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder","author":"Johnco","year":"2020","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib468","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib469","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1520-6394(1998)8:3<121::AID-DA4>3.0.CO;2-P","article-title":"Role of perceived danger in the mediation of obsessive-compulsive washing","volume":"8","author":"Jones","year":"1998","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib470","article-title":"The efficacy of exposure and response prevention for geriatric obsessive compulsive disorder: a clinical case illustration","volume":"2012","author":"Jones","year":"2012","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib471","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.chc.2022.03.012","article-title":"Pharmacotherapy of Attention-Deficit\/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder","volume":"31","author":"Joshi","year":"2022","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib472","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.euroneuro.2014.06.014","article-title":"Treatment with Ziprasidone for schizophrenia patients with OCD","volume":"24","author":"Juven-Wetzler","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib473","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/JCP.0b013e3182668568","article-title":"Neonatal Complications After Maternal Concomitant Use of SSRI and Other Central Nervous System Active Drugs During the Second or Third Trimester of Pregnancy","volume":"32","author":"K\u00e4ll\u00e9n","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib474","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1291077","article-title":"Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy","volume":"14","author":"Kaltenboeck","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib475","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1440-1819.2004.01278.x","article-title":"Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients","volume":"58","author":"Kamijima","year":"2004","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib476","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1034\/j.1600-0447.2002.01261.x","article-title":"Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine","volume":"106","author":"Kampman","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib477","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4088\/JCP.08m04500","article-title":"A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder","volume":"70","author":"Kang","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib478","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.comppsych.2018.11.013","article-title":"Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder","volume":"89","author":"Karaguzel","year":"2019","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib479","article-title":"Intravenous clomipramine for treatment-resistant obsessive-compulsive disorder","volume":"19","author":"Karameh","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib480","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ana.25321","article-title":"Lamotrigine clearance increases by 5 weeks gestational age: Relationship to estradiol concentrations and gestational age","volume":"84","author":"Karanam","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib481","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/13554790601125957","article-title":"Non-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations","volume":"12","author":"Karnik","year":"2006","journal-title":"Neurocase"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib482","series-title":"The epidemiology of obsessive compulsive disorder in five US communities","author":"Karno","year":"1988"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib483","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0006-3223(90)90408-T","article-title":"Clomipramine in obsessive-compulsive disorder","volume":"28","author":"Katz","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib484","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib485","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19ac13182","article-title":"Pharmacotherapy for treatment-resistant obsessive-compulsive disorder","volume":"81","author":"Kayser","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib486","doi-asserted-by":"crossref","DOI":"10.1002\/da.23032","article-title":"Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study","author":"Kayser","year":"2020","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib487","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000001179","article-title":"Cannabinoid augmentation of exposure-based psychotherapy for obsessive-compulsive disorder","author":"Kayser","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib488","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2780","article-title":"Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive-compulsive disorder: A double blind randomized clinical trial","volume":"36","author":"Kazemi","year":"2021","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib489","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1590\/2237-6089-2017-0061","article-title":"Clinical and familial profile of bipolar disorder with and without obsessive-compulsive disorder: an Indian study","volume":"39","author":"Kazhungil","year":"2017","journal-title":"Trends Psychiatry Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib490","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0019-5545.192001","article-title":"Management of obsessive-compulsive disorder comorbid with bipolar disorder","volume":"58","author":"Kazhungil","year":"2016","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib491","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0542-11.2011","article-title":"Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI","author":"Keeser","year":"2011","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.12.039_bib492","doi-asserted-by":"crossref","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","article-title":"Toward achieving optimal response: understanding and managing antidepressant side effects","volume":"10","author":"Kelly","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib493","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/YIC.0b013e32809913b6","article-title":"Open-label escitalopram treatment for pathological skin picking","volume":"22","author":"Keuthen","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib494","first-page":"104","article-title":"Lamotrigine augmentation versus placebo in serotonin reuptake inhibitors-resistant obsessive-compulsive disorder: A randomized controlled trial","volume":"11","author":"Khalkhali","year":"2016","journal-title":"Iran. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib495","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.npbr.2019.07.003","article-title":"Association of bipolar I disorder with obsessive compulsive disorder: A clinical study from Pakistan","volume":"33","author":"Khan","year":"2019","journal-title":"Neurol. Psychiatr. Brain Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib496","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2013.12.051","article-title":"Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study","author":"Khodaie-Ardakani","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib497","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1531","article-title":"Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive-compulsive disorder in patients with bipolar disorder: Double-blind, randomized clinical trial","volume":"6","author":"Khorshidian","year":"2023","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib498","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2017.05.032","article-title":"The relation of childhood trauma to suicide ideation in patients suffering from obsessive-compulsive disorder with lifetime suicide attempts","author":"Khosravani","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib499","doi-asserted-by":"crossref","first-page":"23","DOI":"10.9758\/cpn.2011.9.1.23","article-title":"Clinical Predictors of Drug Response in Patients with Obsessive-Compulsive Disorder","volume":"9","author":"Kim","year":"2011","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000505876","article-title":"Clozapine-associated obsessive-compulsive symptoms and their management: A systematic review and analysis of 107 reported cases","volume":"89","author":"Kim","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib501","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2015.12.018","article-title":"Alexithymia and perfectionism traits are associated with suicidal risk in patients with obsessive-compulsive disorder","author":"Kim","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib502","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2014.05.017","article-title":"Impact of comorbid anxiety disorders and obsessive\u2013compulsive disorder on 24-month clinical outcomes of bipolar I disorder","volume":"166","author":"Kim","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib503","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamapediatrics.2013.2698","article-title":"Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: A multisite randomized clinical trial","volume":"167","author":"King","year":"2013","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior: Citalopram Ineffective in Children With Autism","volume":"66","author":"King","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib505","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1039856216671664","article-title":"Methylphenidate in the treatment of an adolescent female with obsessive-compulsive disorder and attention deficit hyperactivity disorder: a case report","volume":"25","author":"King","year":"2017","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib506","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0141347300014038","article-title":"A Clinical Pilot Study of Cognitive-behavioural Therapy for Anxiety Disorders in the Elderly","volume":"19","author":"King","year":"1991","journal-title":"Behav. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib507","article-title":"St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study","author":"Kobak","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib508","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152422","article-title":"A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom","volume":"127","author":"Kochar","year":"2023","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib509","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00019442-199700530-00004","article-title":"Clinical Features of Obsessive-Compulsive Disorder in Elderly Patients","volume":"5","author":"Kohn","year":"1997","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib510","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0006-3223(85)90120-9","article-title":"Obsessive-compulsive symptoms following stimulants","volume":"20","author":"Koizumi","year":"1985","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib511","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ern.09.148","article-title":"Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder","volume":"10","author":"Koo","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib512","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v66n0312","article-title":"Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder","author":"Koran","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib513","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.08m04605","article-title":"Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder","author":"Koran","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib514","doi-asserted-by":"crossref","DOI":"10.1097\/01.jcp.0000195112.24769.b3","article-title":"Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder","author":"Koran","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib515","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4088\/JCP.v66n0415","article-title":"Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation","volume":"66","author":"Koran","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib516","first-page":"88","article-title":"Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive Disorder","volume":"159","author":"Koran","year":"2002","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib517","first-page":"5","article-title":"Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib518","article-title":"Use of selective serotonin reuptake inhibitor medications for the treatment of child and adolescent mental illness","author":"Korczak","year":"2018","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib519","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fpsyt.2019.00523","article-title":"The effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: A systematic review and meta-analysis","volume":"10","author":"Kotapati","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib520","first-page":"89","article-title":"Obsessive-compulsive symptoms secondary to methylphenidate treatment","volume":"46","author":"Kotsopoulos","year":"2001","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib521","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004583-199802000-00001","article-title":"METHYLPHENIDATE-INDUCED obsessive-compulsiveness","volume":"37","author":"Kouris","year":"1998","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib522","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/archdischild-2014-306934","article-title":"Obsessive-compulsive disorder in children and adolescents","volume":"100","author":"Krebs","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib523","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1475-3588.2009.00548.x","article-title":"Treatment\u2010resistant Obsessive\u2010compulsive Disorder in Young People: Assessment and Treatment Strategies","volume":"15","author":"Krebs","year":"2010","journal-title":"Child Adolesc. Ment. Health"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib524","series-title":"The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-Compulsive Disorder","first-page":"185","article-title":"Chapter 10 - Relapse Prevention Strategies for Young People With OCD (After CBT)","author":"Krebs","year":"2018"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib525","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00004714-199904000-00013","article-title":"Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder","volume":"19","author":"Kronig","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib526","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2012.10.006","article-title":"Quality of life in obsessive-compulsive disorder: the role of mediating variables","volume":"206","author":"Kugler","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib527","first-page":"106","article-title":"Third wave therapies of cognitive behavioral therapy for obsessive compulsive disorder: A reasonable add-on therapy for CBT? State of the art","volume":"66","author":"Kulz","year":"2016","journal-title":"Psychother. Psychosom. Med. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib528","article-title":"Safety and efficacy of adjunctive transcranial direct current stimulation in treatment-resistant obsessive-compulsive disorder: An open-label trial","author":"Kumar","year":"2019","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib529","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/15622970903036846","article-title":"Late-onset obsessive compulsive disorder associated with possible gliomatosis cerebri","volume":"10","author":"Kumar","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib530","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1542\/peds.2007-2657","article-title":"Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study","volume":"121","author":"Kurlan","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib531","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12888-018-1887-4","article-title":"Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment","volume":"18","author":"Kvale","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib532","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13249","article-title":"Effect of D-cycloserine on the effect of concentrated exposure and response prevention in difficult-to-treat obsessive-compulsive disorder: A randomized clinical trial","author":"Kvale","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib533","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.9566","article-title":"Therapist-assisted internet-based cognitive behavioral therapy versus progressive relaxation in obsessive-compulsive disorder: Randomized controlled trial","volume":"20","author":"Kyrios","year":"2018","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib534","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1007\/s10803-018-3645-3","article-title":"Presentation and Correlates of Hoarding Behaviors in Children with Autism Spectrum Disorders and Comorbid Anxiety or Obsessive-Compulsive Symptoms","volume":"48","author":"La Buissonni\u00e8re-Ariza","year":"2018","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib535","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1503\/jpn.190079","article-title":"Effectiveness and safety of neuroablation for severe and treatment-resistant obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"45","author":"Lai","year":"2020","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib536","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib537","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/0706743716659061","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Introduction and methods","volume":"61","author":"Lam","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib538","article-title":"Clinical validation of the parent-report Toronto Obsessive-Compulsive Scale (TOCS): A pediatric open-source rating scale","volume":"1","author":"Lambe","year":"2021","journal-title":"J Child Psychol Psychiatry Adv"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib539","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jad.2009.06.010","article-title":"Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder","volume":"121","author":"Landeros-Weisenberger","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib540","doi-asserted-by":"crossref","first-page":"e1576","DOI":"10.4088\/JCP.15r10164","article-title":"Glutamatergic agents as add-on medication for the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"77","author":"Laoutidis","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib541","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41746-019-0093-1","article-title":"Using science to sell apps: Evaluation of mental health app store quality claims","volume":"2","author":"Larsen","year":"2019","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib542","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.2196\/mhealth.6020","article-title":"Quantifying app store dynamics: Longitudinal tracking of mental health apps","volume":"4","author":"Larsen","year":"2016","journal-title":"JMIR mHealth uHealth"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib543","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/cap.2014.0080","article-title":"Therapeutic Plasma Apheresis as a Treatment for 35 Severely Ill Children and Adolescents with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections","volume":"25","author":"Latimer","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib544","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","article-title":"A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: The Bergen 4-day treatment","volume":"10","author":"Launes","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib545","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1586\/14737175.2016.1126181","article-title":"Family accommodation in obsessive-compulsive and anxiety disorders: a five-year update","volume":"16","author":"Lebowitz","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib546","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/da.20669","article-title":"Obsessive\u2013compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V","volume":"27","author":"Leckman","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib547","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib548","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/07351692109348933","article-title":"Integrating Behavior Modification and Pharmacotherapy With the Psychoanalytic Treatment of Obsessive-Compulsive Disorder: A Case Study","volume":"21","author":"Leib","year":"2001","journal-title":"Psychoanal. Inq."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib549","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ageing\/14.5.257","article-title":"A brief review of cognitive-behavioural treatments in old age","volume":"14","author":"Leng","year":"1985","journal-title":"Age Ageing"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib550","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaac.2016.09.515","article-title":"Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial","volume":"56","author":"Lenhard","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib551","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00004583-199407000-00003","article-title":"Clonazepam as an Augmenting Agent in the Treatment of Childhood-Onset Obsessive-Compulsive Disorder","volume":"33","author":"Leonard","year":"1994","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib552","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1089\/cap.2018.0151","article-title":"Clinical-serological characterization and treatment outcome of a large cohort of Italian children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection and pediatric acute neuropsychiatric syndrome","volume":"29","author":"Lepri","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib553","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial","volume":"297","author":"Lesp\u00e9rance","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib554","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.psychres.2010.08.021","article-title":"Refining clinical judgment of treatment outcome in obsessive\u2013compulsive disorder","volume":"185","author":"Lewin","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib555","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2014.02.001","article-title":"Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: A pilot randomized controlled trial","author":"Lewin","year":"2014","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib556","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.brat.2011.06.001","article-title":"The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder","volume":"49","author":"Lewin","year":"2011","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib557","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/cap.2019.0041","article-title":"N-acetylcysteine for pediatric obsessive-compulsive disorder: A small pilot study","volume":"30","author":"Li","year":"2020","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib558","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biopsych.2021.04.006","article-title":"A unified functional network target for deep brain stimulation in obsessive-compulsive disorder","volume":"90","author":"Li","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib559","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41398-021-01453-0","article-title":"Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"11","author":"Liang","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib560","doi-asserted-by":"crossref","DOI":"10.1177\/2045125312462233","article-title":"Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder","author":"Liddell","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib561","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/wps.20673","article-title":"The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials","volume":"18","author":"Linardon","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib562","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/eat.22833","article-title":"Clinicians' perspective on an app for patient self-monitoring in eating disorder treatment","volume":"51","author":"Lindgreen","year":"2018","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib563","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.171.2.135","article-title":"Controlled trial of exposure and response prevention in obsessive-compulsive disorder","volume":"171","author":"Lindsay","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib564","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/cap.2020.0051","article-title":"Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis","volume":"31","author":"Liu","year":"2021","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib565","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/IJGM.S318069","article-title":"Continuous Theta-Burst Stimulation Over the Right Orbitofrontal Cortex in Treatment-Resistant Obsessive-Compulsive Disorder Treatment: A Randomized Sham-Controlled Trial","volume":"14","author":"Liu","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib566","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","article-title":"Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: A systematic review and meta-analysis","volume":"74","author":"Locher","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib567","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.comppsych.2014.05.020","article-title":"Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)","volume":"55","author":"Lochner","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib568","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1017\/S1041610210000451","article-title":"Electroconvulsive therapy for treatment of late-onset obsessive compulsive disorder","volume":"22","author":"Loi","year":"2010","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib569","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114756","article-title":"Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: A meta-analysis of cohort studies","volume":"316","author":"Lou","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib570","first-page":"36","article-title":"Late onset obsessive-compulsive disorder (OCD): a case report","volume":"48","author":"Lozano-Vicario","year":"2020","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib571","first-page":"50","article-title":"Antidepressant-induced activation in children and adolescents: Risk, recognition and management","volume":"48","author":"Luft","year":"2018","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib572","doi-asserted-by":"crossref","DOI":"10.1080\/02791072.2020.1849879","article-title":"Long-term amelioration of OCD symptoms in a patient with chronic consumption of psilocybin-containing mushrooms","author":"Lugo-Radillo","year":"2021","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib573","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1967","article-title":"Effect of Internet-Based vs Face-to-Face Cognitive Behavioral Therapy for Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial","volume":"5","author":"Lundstr\u00f6m","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib574","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2147\/NDT.S121140","article-title":"Transcranial magnetic stimulation in the treatment of obsessive\u2013compulsive disorder: current perspectives","volume":"14","author":"Lusicic","year":"2018","journal-title":"NDT"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2020.100561","article-title":"Internet-based cognitive behavioural therapy for treating symptoms of obsessive compulsive disorder in routine care","author":"Luu","year":"2020","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib576","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3760\/cma.j.issn.0366-6999.20131994","article-title":"A randomized double-blinded sham-controlled trial of alpha electroencephalogram-guided transcranial magnetic stimulation for obsessive-compulsive disorder","volume":"127","author":"Ma","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib577","first-page":"4897","article-title":"Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials","volume":"7","author":"Ma","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib578","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2014.09.012","article-title":"Internet cognitive behavioural treatment for obsessive compulsive disorder: A randomised controlled trial","author":"Mahoney","year":"2014","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib579","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004850-200101000-00004","article-title":"Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder","volume":"16","author":"Maina","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib580","first-page":"382","article-title":"Family-focused treatments for obsessive-compulsive disorder","volume":"3","author":"Maina","year":"2006","journal-title":"Clin. Neuropsychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib581","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/acps.13568","article-title":"Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive\u2013compulsive disorder: A network meta-analysis","volume":"148","author":"Maiti","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib582","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2019.102110","article-title":"Imagery rescripting as an adjunct clinical intervention for obsessive compulsive disorder","volume":"66","author":"Maloney","year":"2019","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib583","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.comppsych.2014.04.010","article-title":"Long-term course of pediatric obsessive\u2013compulsive disorder: 3 years of prospective follow-up","volume":"55","author":"Mancebo","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib584","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.beth.2010.10.002","article-title":"Patient utilization of cognitive-behavioral therapy for OCD","volume":"42","author":"Mancebo","year":"2011","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib585","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.comppsych.2007.05.016","article-title":"Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder","volume":"49","author":"Mancebo","year":"2008","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib586","article-title":"Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial","author":"Manche Gowda","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib587","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1017\/S1461145711000575","article-title":"Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: A randomized controlled trial","volume":"14","author":"Mansur","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib588","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fnbeh.2014.00152","article-title":"A case of musical preference for Johnny Cash following deep brain stimulation of the nucleus accumbens","volume":"8","author":"Mantione","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib589","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S1461145709990435","article-title":"Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder","volume":"13","author":"Mantovani","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib590","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.2240","article-title":"Plasma fluvoxamine levels and OCD symptoms\/response in adult patients","volume":"27","author":"Marazziti","year":"2012","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib591","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1017\/S1092852900014024","article-title":"Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients","volume":"13","author":"Marazziti","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib592","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2006.09.035","article-title":"Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder","author":"March","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib593","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.comppsych.2011.01.001","article-title":"Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study","volume":"52","author":"Marcks","year":"2011","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib594","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib595","article-title":"Buspirone augmentation of fluoxetine in obsessive-compulsive disorder","author":"Markovitz","year":"1990","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib596","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/da.20694","article-title":"Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms","volume":"27","author":"Marques","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib597","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1891\/1933-3196.6.1.2","article-title":"EMDR treatment of obsessive-compulsive disorder: Preliminary research","volume":"6","author":"Marr","year":"2012","journal-title":"J. EMDR Practice Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib598","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852916000110","article-title":"Obsessive compulsive and related disorders: comparing DSM-5 and ICD-11","author":"Marras","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib599","doi-asserted-by":"crossref","DOI":"10.1002\/cpp.2120","article-title":"A randomized controlled trial comparing EMDR and CBT for obsessive-compulsive disorder","author":"Marsden","year":"2018","journal-title":"Clin. Psychol. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib600","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00787-020-01478-8","article-title":"Co-occurring obsessive\u2013compulsive disorder and autism spectrum disorder in young people: prevalence, clinical characteristics and outcomes","volume":"29","author":"Martin","year":"2020","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib601","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12821","article-title":"Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"81","author":"Martinho","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib602","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jpsychires.2013.04.003","article-title":"Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: A naturalistic comparative study","volume":"47","author":"Masi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib603","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/JCP.0b013e3181fab7b1","article-title":"Aripiprazole Augmentation in 39 Adolescents With Medication-Resistant Obsessive-Compulsive Disorder","volume":"30","author":"Masi","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib604","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2016.3955","article-title":"D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: A systematic review and meta-analysis of individual participant data","author":"Mataix-Cols","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib605","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/wps.20299","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib606","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.156.9.1409","article-title":"Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder","volume":"156","author":"Mataix-Cols","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib607","article-title":"A 5-year course of predominantly obsessive vs. mixed subtypes of obsessive-compulsive disorder","author":"Math","year":"2007","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib608","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11920-019-1015-2","article-title":"Epidemiological and clinical gender differences in OCD","volume":"21","author":"Mathes","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib609","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jad.2020.12.082","article-title":"A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder","volume":"282","author":"Mathur","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib610","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1440-1819.2007.01635.x","article-title":"Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine","volume":"61","author":"Matsui","year":"2007","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib611","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12991-021-00365-z","article-title":"The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report","volume":"20","author":"Matteo","year":"2021","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib612","first-page":"119","article-title":"The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder","volume":"26","author":"Mavissakalian","year":"1990","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib613","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-199008000-00005","article-title":"Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels","volume":"10","author":"Mavissakalian","year":"1990","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib614","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1176\/ajp.142.5.572","article-title":"Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II","volume":"142","author":"Mavissakalian","year":"1985","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib615","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1071\/AH16276","article-title":"Reductions in quality of life and increased economic burden associated with mental disorders in an Australian adult sample","volume":"43","author":"McCallum","year":"2019","journal-title":"Aust. Health Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib616","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in Children with Autism and Serious Behavioral Problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib617","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib618","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004714-199310000-00008","article-title":"The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder","volume":"13","author":"McDougle","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib619","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","article-title":"Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics","volume":"51","author":"McDougle","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib621","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.1996.01830110037005","article-title":"A Double-blind, Placebo-controlled study of Fluvoxamine in Adults With Autistic Disorder","volume":"53","author":"Mcdougle","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib622","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004714-199106000-00005","article-title":"A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy","volume":"11","author":"McDougle","year":"1991","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib623","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/00030651050530011301","article-title":"Child Psychoanalysis and Obsessive-Compulsive Symptoms: The Treatment of a Ten-Year-Old Boy","volume":"53","author":"McGehee","year":"2005","journal-title":"J. Am. Psychoanal. Assoc."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib624","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S2215-0366(16)30264-4","article-title":"Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials","volume":"3","author":"McGirr","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib625","doi-asserted-by":"crossref","DOI":"10.1002\/da.22389","article-title":"A meta-analysis of cognitive behavior therapy and medication for child obsessive-compulsive disorder: Moderators of treatment efficacy, response, and remission","author":"McGuire","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib626","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cbpra.2017.12.003","article-title":"An inhibitory learning approach to cognitive-behavioral therapy for children and adolescents","volume":"26","author":"McGuire","year":"2019","journal-title":"Cognit. Behav. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib627","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jcpp.12818","article-title":"Editorial perspective: exposures in cognitive behavior therapy for pediatric obsessive-compulsive disorder: addressing common clinician concerns","volume":"59","author":"McGuire","year":"2018","journal-title":"JCPP (J. Child Psychol. Psychiatry)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib628","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4088\/JCP.15r10334","article-title":"A meta-analysis of D-cycloserine in exposure-based treatment: moderators of treatment efficacy, response, and diagnostic remission","volume":"78","author":"McGuire","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib629","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1037\/0022-006X.69.2.205","article-title":"Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder","volume":"69","author":"McLean","year":"2001","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib630","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2015.3105","article-title":"Mortality among persons with obsessive-compulsive disorder in Denmark","volume":"73","author":"Meier","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib631","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00787-018-1137-9","article-title":"A solid majority remit following evidence-based OCD treatments: a 3-year naturalistic outcome study in pediatric OCD","volume":"27","author":"Melin","year":"2018","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib632","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaac.2019.01.010","article-title":"Treatment Gains Are Sustainable in Pediatric Obsessive-Compulsive Disorder: Three-Year Follow-Up From the NordLOTS","volume":"59","author":"Melin","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib633","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.rpsm.2019.01.003","article-title":"Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology","volume":"12","author":"Menchon","year":"2019","journal-title":"Rev. Psiquiat\u00eda Salud Ment."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib634","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41380-019-0562-6","article-title":"A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder","volume":"26","author":"Menchon","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib635","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1037\/a0012652","article-title":"Decreased family accommodation associated with improved therapy outcome in pediatric obsessive\u2013compulsive disorder","volume":"77","author":"Merlo","year":"2009","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib636","first-page":"826","article-title":"Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [ 11 C]DASB Positron Emission Tomography Study","volume":"161","author":"Meyer","year":"2004","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib637","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/11634510-000000000-00000","article-title":"Elucidating the mechanism of action of pregabalin: alpha(2)delta as a therapeutic target in anxiety","volume":"26","author":"Mico","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib638","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-018-0054-0","article-title":"Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder","volume":"24","author":"Miguel","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib639","doi-asserted-by":"crossref","DOI":"10.1016\/j.tics.2011.11.003","article-title":"Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways","author":"Milad","year":"2012","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib640","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0706743716660033","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 4. Neurostimulation treatments","volume":"61","author":"Milev","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib641","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S2215-0366(16)30281-4","article-title":"Network meta-analyses and treatment recommendations for obsessive-compulsive disorder","volume":"3","author":"Ming","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib642","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/01.jcp.0000144892.52858.7d","article-title":"Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation","volume":"24","author":"Misri","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib643","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.4088\/JCP.v65n0913","article-title":"The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial","volume":"65","author":"Misri","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib644","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5498\/wjp.v11.i8.477","article-title":"Hypomanic\/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis","volume":"11","author":"Miuli","year":"2021","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib645","doi-asserted-by":"crossref","DOI":"10.1002\/gps.939","article-title":"Memantine: update on the current evidence","author":"Mobius","year":"2003","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib646","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112602","article-title":"A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder","author":"Modarresi","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib647","article-title":"Memantine augmentation improves symptoms in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: A randomized controlled trial","author":"Modarresi","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib648","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000228248","article-title":"The selection and design of control conditions for randomized controlled trials of psychological interventions","volume":"78","author":"Mohr","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib649","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.2196\/jmir.6645","article-title":"Intellicare: An eclectic, skills-based app suite for the treatment of depression and anxiety","volume":"19","author":"Mohr","year":"2017","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib650","doi-asserted-by":"crossref","DOI":"10.1097\/YCT.0000000000000218","article-title":"Efficacy of cathodal transcranial direct current stimulation over the left orbitofrontal cortex in a patient with treatment-resistant obsessive-compulsive disorder","author":"Mondino","year":"2015","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib651","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004850-200103000-00002","article-title":"Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder","volume":"16","author":"Montgomery","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib652","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0924-977X(93)90266-O","article-title":"A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group","volume":"3","author":"Montgomery","year":"1993","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib653","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2013.3524","article-title":"The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders","author":"Monzani","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib654","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib655","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbtep.2016.11.003","article-title":"Imagery rescripting as a clinical intervention for aversive memories: A meta-analysis","author":"Morina","year":"2017","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib656","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00406-019-01080-3","article-title":"Effects and side effects of a transdiagnostic bias modification intervention in a mixed sample with obsessive-compulsive and\/or depressive symptoms-a randomized controlled trial","volume":"270","author":"Moritz","year":"2020","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib657","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2017.12.009","article-title":"New wine in an old bottle? Evaluation of myMCT as an integrative bibliotherapy for obsessive-compulsive disorder","author":"Moritz","year":"2018","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib658","doi-asserted-by":"crossref","DOI":"10.1177\/2043808718820683","article-title":"Acceptance and efficacy of a metacognitive self-help intervention in an Arabic-speaking mixed patient sample with depression and\/or obsessive\u2013compulsive disorder: A randomized controlled trial","author":"Moritz","year":"2019","journal-title":"J. Exp. Psychopathol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib659","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-021-01307-9","article-title":"A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder","volume":"11","author":"Mosley","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib660","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852919001500","article-title":"Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial","author":"Mowla","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib661","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S1092852912000065","article-title":"Topiramate augmentation in resistant OCD: A double-blind placebo-controlled clinical trial","volume":"15","author":"Mowla","year":"2010","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib662","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10072-011-0480-0","article-title":"Obsessive-compulsive disorder: a new risk factor for Alzheimer disease?","volume":"32","author":"Mrabet Khiari","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib663","first-page":"1","article-title":"Adjunctive neuronavigated accelerated continuous theta-burst stimulation in obsessive-compulsive disorder: a randomized sham-controlled study","author":"Mukherjee","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib664","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.brs.2021.10.388","article-title":"Pressing ethical issues in considering pediatric deep brain stimulation for obsessive-compulsive disorder","volume":"14","author":"Mu\u00f1oz","year":"2021","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib665","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psychres.2015.03.012","article-title":"Outcomes of cognitive behaviour therapy for obsessive-compulsive disorder in young people with and without autism spectrum disorders: A case controlled study","volume":"228","author":"Murray","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib666","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0024-3205(80)90469-5","article-title":"Striatal opiate receptors: pre- and postsynaptic localization","volume":"27","author":"Murrin","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib667","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.mp.4001939","article-title":"Mechanisms of fear extinction","volume":"12","author":"Myers","year":"2007","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib668","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.673390","article-title":"A naturalistic study of the maintenance of gains made with treatment of patients with profound treatment-refractory obsessive-compulsive disorder","author":"Nadeem","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib669","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/pcn.12803","article-title":"Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control","volume":"73","author":"Naderi","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib670","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/cap.2015.0083","article-title":"Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up","volume":"26","author":"Naguy","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib671","doi-asserted-by":"crossref","DOI":"10.1080\/13651501.2020.1773503","article-title":"Impulsivity, hostility and suicidality in patients diagnosed with obsessive compulsive disorder","author":"Nagy","year":"2020","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib672","doi-asserted-by":"crossref","DOI":"10.4103\/IJPSYM.IJPSYM_388_16","article-title":"Efficacy of transcranial direct current stimulation in the treatment-resistant patients who suffer from severe obsessive-compulsive disorder","author":"Najafi","year":"2017","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib673","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000086317","article-title":"A randomized controlled trial of Japanese patients with obsessive-compulsive disorder--effectiveness of behavior therapy and fluvoxamine","volume":"74","author":"Nakatani","year":"2005","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib674","article-title":"Successful application of add-on transcranial direct current stimulation (tDCS) for treatment of SSRI resistant OCD","author":"Narayanaswamy","year":"2014","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib675","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00702-019-02098-6","article-title":"Theta burst stimulation for the treatment of obsessive-compulsive disorder: a pilot study","volume":"126","author":"Naro","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib676","series-title":"Drugs and Lactation Database (LactMed\u00ae)","year":"2024"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib677","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.62","article-title":"Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study","volume":"4","author":"Nauczyciel","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib678","doi-asserted-by":"crossref","DOI":"10.3109\/13651501.2011.590210","article-title":"Comparison of eye movement desensitization and reprocessing with citalopram in treatment of obsessive-compulsive disorder","author":"Nazari","year":"2011","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib679","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cbpra.2018.01.002","article-title":"State of the field of mental health apps","volume":"25","author":"Neary","year":"2018","journal-title":"Cognit. Behav. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib680","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archpsyc.57.4.358","article-title":"A family study of obsessive compulsive disorder","volume":"57","author":"Nestadt","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib681","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2022.152305","article-title":"Optimizing first line treatments for adults with OCD","volume":"115","author":"Nezgovorova","year":"2022","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib683","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2022.100982","article-title":"Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial","volume":"29","author":"Niemeyer","year":"2022","journal-title":"Contemporary Clin. Trials Commun."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib684","doi-asserted-by":"crossref","DOI":"10.1515\/REVNEURO.2010.21.2.119","article-title":"Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies","author":"Nikolaus","year":"2010","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib685","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v67n0103","article-title":"High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial","volume":"67","author":"Ninan","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib686","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v61n0111","article-title":"A Placebo-Controlled Trial of Cognitive-Behavioral Therapy and Clomipramine in Trichotillomania","volume":"61","author":"Ninan","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib687","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/08039488.2018.1486454","article-title":"The importance of insight, avoidance behavior, not-just-right perception and personality traits in pediatric obsessive-compulsive disorder (OCD): a naturalistic clinical study","volume":"72","author":"Nissen","year":"2018","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib688","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","author":"Norberg","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib689","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0447.2006.00767.x","article-title":"Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder","volume":"113","author":"O'Connor","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib690","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s00213-017-4685-7","article-title":"A comparative study of QT prolongation with serotonin reuptake inhibitors","volume":"234","author":"Ojero-Senard","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib691","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004856.pub2","article-title":"Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents","author":"O'Kearney","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib692","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2012.08.020","article-title":"Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators","author":"Olatunji","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib693","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jpsychires.2010.02.011","article-title":"Mediation of symptom changes during inpatient treatment for eating disorders: the role of obsessive-compulsive features","volume":"44","author":"Olatunji","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib694","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1348\/014466510X490073","article-title":"Time-intensive cognitive behaviour therapy for obsessive-compulsive disorder: A case series and matched comparison group","volume":"50","author":"Oldfield","year":"2011","journal-title":"Br. J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib695","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/da.20789","article-title":"Evidence for successful implementation of exposure and response prevention in a naturalistic group format for pediatric OCD","volume":"28","author":"Olino","year":"2011","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib696","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00406-007-0798-z","article-title":"Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?","volume":"258","author":"\u00d6nder","year":"2008","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib697","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/PRBM.S75106","article-title":"Cognitive-behavioral therapy for obsessive-compulsive disorder: access to treatment, prediction of long-term outcome with neuroimaging","volume":"8","author":"O'Neill","year":"2015","journal-title":"Psychol. Res. Behav. Manag."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib698","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2016.03.006","article-title":"Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say?","author":"Ong","year":"2016","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib699","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2017.0995","article-title":"Association of streptococcal throat infection with mental disorders: Testing key aspects of the PANDAS hypothesis in a nationwide study","author":"Orlovska","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib700","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.psychres.2018.07.018","article-title":"The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study","volume":"268","author":"Osland","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib701","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2022.104170","article-title":"Cognitive behavior therapy for obsessive-compulsive disorder in routine clinical care: A systematic review and meta-analysis","volume":"159","author":"\u00d6st","year":"2022","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib702","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2015.06.003","article-title":"Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014","author":"\u00d6st","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib703","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2016.08.003","article-title":"Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis","author":"\u00d6st","year":"2016","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib704","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aur.109","article-title":"A pharmacogenetic study of escitalopram in autism spectrum disorders","volume":"3","author":"Owley","year":"2010","journal-title":"Autism Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib705","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.chi.0000153229.80215.a0","article-title":"An open-label trial of escitalopram in pervasive developmental disorders","volume":"44","author":"Owley","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib706","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.psychres.2015.11.002","article-title":"Comorbid obsessive\u2013compulsive disorder with bipolar disorder: A distinct form?","volume":"230","author":"Ozdemiroglu","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib707","first-page":"1249","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib708","article-title":"Extract of Valerian Root (Valeriana Officinalis L.) vs. Placebo in Treatment of Obsessive-Compulsive Disorder: A Randomized Double-Blind Study","volume":"8","author":"Pakseresht","year":"2011","journal-title":"J. Compl. Integr. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib709","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1517\/14656566.2014.964208","article-title":"Pharmacologic treatment of obsessive-compulsive disorder comorbidity","volume":"15","author":"Pallanti","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib710","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S1092852913000618","article-title":"Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity","volume":"19","author":"Pallanti","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib711","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145702002900","article-title":"Treatment non-response in OCD: Methodological issues and operational definitions","volume":"5","author":"Pallanti","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib712","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0269881116628427","article-title":"Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial","volume":"30","author":"Pallanti","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib713","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","author":"Pallanti","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib714","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v65n1015","article-title":"Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study","author":"Pallanti","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib715","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4088\/JCP.v63n0908","article-title":"Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial","volume":"63","author":"Pallanti","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib716","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0924-9338(99)80725-1","article-title":"Citalopram for treatment-resistant obsessive-compulsive disorder","volume":"14","author":"Pallanti","year":"1999","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib717","doi-asserted-by":"crossref","DOI":"10.1080\/13554794.2017.1319492","article-title":"Prefrontal tDCS and sertraline in obsessive compulsive disorder: a case report and review of the literature","author":"Palm","year":"2017","journal-title":"Neurocase"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib718","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaac.2016.01.008","article-title":"The Toronto Obsessive-Compulsive Scale: Psychometrics of a dimensional measure of obsessive-compulsive traits","volume":"55","author":"Park","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib719","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7356","article-title":"A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism","volume":"11","author":"Parker","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib720","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1176\/ajp.145.12.1521","article-title":"Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder","volume":"145","author":"Pato","year":"1988","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib721","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpsychires.2016.08.015","article-title":"The use of waitlists as control conditions in anxiety disorders research","volume":"83","author":"Patterson","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib722","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jcpt.12370","article-title":"N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial","volume":"41","author":"Paydary","year":"2016","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib723","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbtep.2015.12.007","article-title":"A systematic review and meta-analysis of self-help therapeutic interventions for obsessive-compulsive disorder: Is therapeutic contact key to overall improvement?","author":"Pearcy","year":"2016","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib724","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib725","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw025","article-title":"Repetitive transcranial magnetic stimulation to supplementary motor area in refractory obsessive-compulsive disorder treatment: A sham-controlled trial","volume":"19","author":"Pelissolo","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib726","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2022.152339","article-title":"Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications","volume":"118","author":"Pellegrini","year":"2022","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib727","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2020.07.115","article-title":"Suicide attempts and suicidal ideation in patients with obsessive-compulsive disorder: A systematic review and meta-analysis","author":"Pellegrini","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib728","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib729","first-page":"947","article-title":"Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A meta-analysis of randomized, sham-controlled trials","volume":"6","author":"Perera","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib730","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/CHI.0b013e3181825a91","article-title":"Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics","volume":"47","author":"Peris","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib731","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib732","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1176\/ajp.144.12.1543","article-title":"Fluvoxamine treatment of obsessive-compulsive disorder","volume":"144","author":"Perse","year":"1987","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib733","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1037\/abn0000660","article-title":"Modeling a multidimensional model of memory performance in obsessive-compulsive disorder: A multilevel meta-analytic review","volume":"130","author":"Persson","year":"2021","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib734","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v63n1207","article-title":"Obsessive-Compulsive-Bipolar Comorbidity: A Systematic Exploration of Clinical Features and Treatment Outcome","volume":"63","author":"Perugi","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib735","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/070674370404900812","article-title":"Effective Use of Olanzapine for Obsessive\u2014Compulsive Symptoms in a Patient with Bipolar Disorder","volume":"49","author":"Petrikis","year":"2004","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib736","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200015050-00007","article-title":"Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study","volume":"15","author":"Pfanner","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib737","first-page":"5","article-title":"Oxytocin and Autism Spectrum Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"50","author":"Phaik Ooi","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib738","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archpsyc.59.4.381","article-title":"A Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder","volume":"59","author":"Phillips","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib739","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4088\/JCP.v59n0404","article-title":"Efficacy and Safety of Fluvoxamine in Body Dysmorphic Disorder","volume":"59","author":"Phillips","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib740","first-page":"887","article-title":"Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial","volume":"173","author":"Phillips","year":"2016","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib741","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4088\/JCP.v64n0615","article-title":"An Open-Label Study of Citalopram in Body Dysmorphic Disorder","volume":"64","author":"Phillips","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib742","series-title":"Obsessive-compulsive disorder in the elderly","author":"Philpot","year":"1998"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib743","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2011.08.003","article-title":"Controlled comparison of family cognitive behavioral therapy and psychoeducation: relaxation training for child obsessive- compulsive disorder","author":"Piacentini","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib744","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/15374410701662790","article-title":"Functional impairment in childhood OCD: development and psychometrics properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R)","volume":"36","author":"Piacentini","year":"2007","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib745","doi-asserted-by":"crossref","DOI":"10.1097\/00004714-199202000-00003","article-title":"A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder","author":"Pigott","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib746","first-page":"156","article-title":"A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder","volume":"12","author":"Pigott","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib747","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2020.151221","article-title":"Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care","volume":"44","author":"Pinheiro","year":"2020","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib748","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jocrd.2012.06.001","article-title":"Development and preliminary psychometric evaluation of a self-rated version of the Family Accommodation Scale for Obsessive-Compulsive Disorder","volume":"2","author":"Pinto","year":"2013","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib749","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/biomedicines11010080","article-title":"The Effects of Transcranial Direct Current Stimulation in Obsessive\u2013Compulsive Disorder Symptoms: A Meta-Analysis and Integrated Electric Fields Modeling Analysis","volume":"11","author":"Pinto","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib750","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4088\/JCP.14m09123","article-title":"Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial","volume":"76","author":"Pittenger","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib751","first-page":"34","article-title":"Clinical treatment of obsessive compulsive disorder","volume":"2","author":"Pittenger","year":"2005","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib752","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0b013e3181727548","article-title":"Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up","author":"Pittenger","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib753","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00787-018-1177-1","article-title":"Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis","volume":"27","author":"Poels","year":"2018","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib754","doi-asserted-by":"crossref","DOI":"10.1002\/cpp.2989","article-title":"Internet\u2010Based Cognitive Behavioural Treatments for Obsessive\u2013Compulsive Disorder: A Systematic Review and Meta\u2010Analysis","volume":"31","author":"Polak","year":"2024","journal-title":"Clin. Psychol. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib755","first-page":"73","volume":"vol. 19","author":"Postorino","year":"2018"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib756","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2014.12.019","article-title":"Factors associated with the duration of untreated illness among patients with obsessive compulsive disorder","author":"Poyraz","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib757","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004850-200015030-00006","article-title":"Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms","volume":"15","author":"Poyurovsky","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib758","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/0269881108099215","article-title":"Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms","volume":"24","author":"Poyurovsky","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib759","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-199903000-00006","article-title":"Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study","volume":"14","author":"Poyurovsky","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib760","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v64n0518c","article-title":"Olanzapine-Sertraline Combination in Schizophrenia With Obsessive-Compulsive Disorder","volume":"64","author":"Poyurovsky","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib761","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1745017901915010075","article-title":"The perception of physical health status in obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"15","author":"Pozza","year":"2019","journal-title":"Clin. Pract. Epidemiol. Ment. Health: CP & EMH"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib762","first-page":"327","article-title":"The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study","volume":"27","author":"Prasko","year":"2006","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib763","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brat.2016.07.012","article-title":"Does cognitive self-consciousness link older adults' cognitive functioning to obsessive-compulsive symptoms?","volume":"85","author":"Prouvost","year":"2016","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib764","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/YIC.0b013e3282f0f0c5","article-title":"High-dose escitalopram for the treatment of obsessive-compulsive disorder","volume":"23","author":"Rabinowitz","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib765","doi-asserted-by":"crossref","first-page":"719","DOI":"10.12740\/PP\/OnlineFirst\/69422","article-title":"Effects of atorvastatin on treatment-resistant obsessive-compulsive disorder: A double-blind randomized trial","volume":"52","author":"Rahim","year":"2018","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib766","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1176\/ajp.155.11.1626f","article-title":"Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior","volume":"155","author":"Rahman","year":"1998","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib767","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(93)91557-9","article-title":"Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization","volume":"631","author":"Rahman","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib768","series-title":"The effect of Yoga on anxiety symptoms in women with obsessive compulsive disorder","year":"2013"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib769","first-page":"232","article-title":"Chemotherapy-induced nausea and vomiting: optimizing prevention and management","volume":"5","author":"Rao","year":"2012","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib770","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1570159X17666190409142555","article-title":"Brain stimulation in obsessive-compulsive disorder (OCD): A systematic review","volume":"17","author":"Rapinesi","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib771","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/HRP.0000000000000274","article-title":"The role of stress in obsessive-compulsive disorder: a narrative review","volume":"28","author":"Raposo-Lima","year":"2020","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib772","first-page":"13","article-title":"Evidence-based assessment of obsessive-compulsive disorder","author":"Rapp","year":"2016","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib773","article-title":"Symptom trajectories of early responders and remitters among youth with OCD","volume":"27","author":"Rech","year":"2020","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib774","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjc.12188","article-title":"Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting","volume":"58","author":"Rector","year":"2019","journal-title":"Br. J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib775","doi-asserted-by":"crossref","DOI":"10.1080\/16506073.2015.1016448","article-title":"A pilot test of the additive benefits of physical exercise to CBT for OCD","author":"Rector","year":"2015","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib776","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.2019.14685","article-title":"Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents with Autism Spectrum Disorders: A Randomized Clinical Trial","volume":"322","author":"Reddihough","year":"2019","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib777","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Reddy","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib778","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.4088\/JCP.v66n0611","article-title":"An 11-to 13-year follow-up of 75 subjects with obsessive-compulsive disorder","volume":"66","author":"Reddy","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib779","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jbtep.2007.11.004","article-title":"An open trial of group metacognitive therapy for obsessive-compulsive disorder","volume":"39","author":"Rees","year":"2008","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib780","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11126-018-9566-7","article-title":"A meta-analysis of the effectiveness of different cortical targets used in repetitive transcranial magnetic stimulation (rTMS) for the treatment of obsessive-compulsive disorder (OCD)","volume":"89","author":"Rehn","year":"2018","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib781","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2021.152223","article-title":"Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials","author":"Reid","year":"2021","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib782","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib783","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1037\/a0034429","article-title":"Randomized controlled trial of parent-enhanced CBT compared with individual CBT for obsessive-compulsive disorder in young people","volume":"81","author":"Reynolds","year":"2013","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib784","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004714-200008000-00004","article-title":"Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics","volume":"20","author":"Reznik","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib785","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13229-019-0274-4","article-title":"Autistic traits in adults who have attempted suicide","volume":"10","author":"Richards","year":"2019","journal-title":"Mol. Autism"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib786","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2022.100321","article-title":"Mindfulness-based psychotherapy in patients with obsessive-compulsive disorder: A meta-analytical Study","volume":"22","author":"Riquelme-Mar\u00edn","year":"2022","journal-title":"Int. J. Clin. Health Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib787","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1352465821000370","article-title":"A pilot study of dialectical behaviour therapy skills training for autistic adults","volume":"50","author":"Ritschel","year":"2022","journal-title":"Behav. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib788","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jcpp.13305","article-title":"Practitioner Review: Pharmacological treatment of attention-deficit\/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis","volume":"62","author":"Rodrigues","year":"2021","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib789","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.09l05805blu","article-title":"Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial","author":"Rodriguez","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib790","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/JCP.0b013e318290115e","article-title":"Does extended release methylphenidate help adults with hoarding disorder?: a case series","volume":"33","author":"Rodriguez","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib791","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.10l06653","article-title":"Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder","author":"Rodriguez","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib792","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib793","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16cr11234","article-title":"Challenges in testing intranasal ketamine in obsessive-compulsive disorder","author":"Rodriguez","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib794","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocrd.2017.10.002","article-title":"Preliminary test of group acceptance and commitment therapy on obsessive-compulsive disorder for patients on optimal dose of selective serotonin reuptake inhibitors","volume":"16","author":"Rohani","year":"2018","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib795","first-page":"630","article-title":"A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression","volume":"181","author":"Rohde","year":"2024","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib796","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.2009.1670","article-title":"Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: A Randomized Controlled Trial","volume":"302","author":"Rollman","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib797","doi-asserted-by":"crossref","DOI":"10.1002\/da.22232","article-title":"Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials","author":"Romanelli","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib798","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004714-200102000-00009","article-title":"Long-Term Treatment of Obsessive-Compulsive Disorder After an Acute Response: A Comparison of Fluoxetine Versus Placebo","volume":"21","author":"Romano","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib799","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12965","article-title":"Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: undefined","volume":"81","author":"Rommel","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib800","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijchp.2019.06.001","article-title":"Family involvement and treatment for young children with obsessive-compulsive disorder: Randomized control study","volume":"19","author":"Rosa-Alcazar","year":"2019","journal-title":"Int. J. Clin. Health Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib801","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2008.07.001","article-title":"Psychological treatment of obsessive-compulsive disorder: a meta-analysis","author":"Rosa-Alc\u00e1zar","year":"2008","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib802","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0006-3223(97)00443-5","article-title":"A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder","volume":"43","author":"Rosenberg","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib803","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1461145701002401","article-title":"Brain anatomy and chemistry may predict treatment response in paediatric obsessive--compulsive disorder","volume":"4","author":"Rosenberg","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib804","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.chi.0000132812.44664.2d","article-title":"Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls","volume":"43","author":"Rosenberg","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib805","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2616492","article-title":"A Case of Comorbid PTSD and Posttraumatic OCD Treated with Sertraline-Aripiprazole Augmentation","volume":"2020","author":"Rossi","year":"2020","journal-title":"Case Reports in Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib806","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.clinph.2009.08.016","article-title":"Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research","volume":"120","author":"Rossi","year":"2009","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib807","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.psychres.2011.10.005","article-title":"Stressful life events and obsessive\u2013compulsive disorder: clinical features and symptom dimensions","volume":"197","author":"Rosso","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib808","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jpsychires.2020.11.009","article-title":"Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites","volume":"137","author":"Roth","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib809","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X16666180828095131","article-title":"Psychopharmacotherapy of obsessive-compulsive symptoms within the framework of Tourette Syndrome","author":"Rothenberger","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib810","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2019.01.017","article-title":"Hoarding symptoms in children and adolescents with obsessive-compulsive disorder: Clinical features and response to cognitive behavioral therapy","author":"Rozenman","year":"2019","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib811","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0000000000000266","article-title":"The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study","volume":"34","author":"Rubin-Kahana","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib812","doi-asserted-by":"crossref","DOI":"10.1097\/01.jcp.0000220524.44905.9f","article-title":"The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder","author":"Rubio","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib813","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.psychres.2014.08.002","article-title":"Predictors of treatment response to intensive cognitive-behavioral therapy for pediatric obsessive-compulsive disorder","volume":"220","author":"Rudy","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib814","first-page":"226","article-title":"Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation","volume":"11","author":"Ruffini","year":"2009","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib815","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib816","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4088\/JCP.12r07917","article-title":"Risk of obsessive-compulsive disorder in pregnant and postpartum women: a meta-analysis","volume":"74","author":"Russell","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib817","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1017\/S0033291707001092","article-title":"Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation","volume":"37","author":"Sachdev","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib818","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/00223891.2018.1428983","article-title":"A Psychometric Examination of the Pathological Obsessive Compulsive Personality Scale (POPS): Initial Study in an Undergraduate Sample","volume":"101","author":"Sadri","year":"2018","journal-title":"J. Pers. Assess."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib819","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4103\/IJPSYM.IJPSYM_53_17","article-title":"Functional impairment and quality of life in patients with obsessive compulsive disorder","volume":"39","author":"Sahoo","year":"2017","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib820","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jad.2014.05.015","article-title":"Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial","volume":"166","author":"Sahraian","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib821","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2018.03.014","article-title":"Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial","volume":"84","author":"Sahraian","year":"2018","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib822","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1017\/S1092852921000572","article-title":"Is quetiapine effective for obsessive and compulsive symptoms in patients with bipolar disorder? A randomized, double-blind, placebo-controlled clinical trial","volume":"27","author":"Sahraian","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib823","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/JCP.0000000000000651","article-title":"Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"37","author":"Sahraian","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib824","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jad.2022.11.007","article-title":"Efficacy of remotely-delivered cognitive behavioural therapy for obsessive-compulsive disorder: An updated meta-analysis of randomised controlled trials","volume":"322","author":"Salazar de Pablo","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib825","article-title":"Impact of comorbid obsessive-compulsive disorder on suicidality in patients with bipolar disorder","author":"Salvo","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib826","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib827","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.janxdis.2013.10.007","article-title":"Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"28","author":"Sanchez-Meca","year":"2014","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib828","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/1362361320909177","article-title":"Felt but Not Seen: Observed Restricted Repetitive Behaviors are Associated with Self-Report \u2013 but not Parent-Report \u2013 OCD Symptoms in Youth with ASD","volume":"24","author":"Santore","year":"2020","journal-title":"Autism"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib829","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/13651501.2016.1233344","article-title":"Bipolar disorder comorbidity in patients with a primary diagnosis of OCD","volume":"21","author":"Saraf","year":"2017","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib830","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.janxdis.2010.03.011","article-title":"Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression","volume":"24","author":"Sarkhel","year":"2010","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib831","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110550","article-title":"N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial","author":"Sarris","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib832","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-015-0272-9","article-title":"N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study","author":"Sarris","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib833","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0976-500X.149144","article-title":"Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis","volume":"6","author":"Sassano-Higgins","year":"2015","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib834","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/scnp.2001.21833","article-title":"Brain-behavior relationships in obsessive-compulsive disorder","volume":"6","author":"Saxena","year":"2001","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib835","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/YIC.0000000000000036","article-title":"Venlafaxine extended-release treatment of hoarding disorder","volume":"29","author":"Saxena","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib836","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.pnpbp.2009.08.021","article-title":"Efficacy of aqueous extract of Echium amoenum in treatment of obsessive\u2013compulsive disorder","volume":"33","author":"Sayyah","year":"2009","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib837","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2011.01.019","article-title":"A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder","author":"Sayyah","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib838","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pnpbp.2009.12.016","article-title":"Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive\u2212 Compulsive Disorder","volume":"34","author":"Sayyah","year":"2010","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib839","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children's Yale-Brown obsessive compulsive scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib840","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jocrd.2014.06.002","article-title":"The prevalence of tic disorders and clinical characteristics in children","volume":"3","author":"Scahill","year":"2014","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib841","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2007.07061016","article-title":"Improvement in refractory obsessive compulsive disorder with dronabinol","author":"Schindler","year":"2008","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib842","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/da.23105","article-title":"Unguided Internet\u2010based cognitive\u2010behavioral therapy for obsessive\u2010compulsive disorder: A randomized controlled trial","volume":"37","author":"Schr\u00f6der","year":"2020","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib843","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jocrd.2016.05.001","article-title":"Efficacy of group psychotherapy for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials","volume":"10","author":"Schwartze","year":"2016","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib844","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psychres.2017.01.025","article-title":"Symptom subtype and quality of life in obsessive-compulsive disorder","volume":"249","author":"Schwartzman","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib845","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004850-199911000-00005","article-title":"Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive \u2013 compulsive disorder: an open trial","volume":"14","author":"Seedat","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib846","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpsychires.2023.06.019","article-title":"Efficacy of stand-alone digital mental health applications for anxiety and depression: A meta-analysis of randomized controlled trials","volume":"164","author":"Seegan","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib847","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaac.2019.05.030","article-title":"Avoidance, insight, impairment recognition concordance, and cognitive-behavioral therapy outcomes in pediatric obsessive-compulsive disorder","volume":"59","author":"Selles","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib848","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2018.04.012","article-title":"Symptom insight in pediatric obsessive-compulsive disorder: Outcomes of an international aggregated cross-sectional sample","author":"Selles","year":"2018","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib849","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10578-014-0435-9","article-title":"Variations in symptom prevalence and clinical correlates in younger versus older youth with obsessive-compulsive disorder","volume":"45","author":"Selles","year":"2014","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib850","doi-asserted-by":"crossref","first-page":"153","DOI":"10.9758\/cpn.2016.14.2.153","article-title":"Adjunctive low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex in patients with treatment-resistant obsessive-compulsive disorder: A randomized controlled trial","volume":"14","author":"Seo","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib851","article-title":"Ondansetron augmentation for treatment-resistant obsessive-compulsive disorder: A randomized placebo-controlled clinical trial","volume":"22","author":"Sepehrmanesh","year":"2019","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib852","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1017\/S1092852900018885","article-title":"Methylphenidate-Induced Obsessive-Compulsive Symptoms in an Elderly Man","volume":"8","author":"Serby","year":"2003","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib853","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib854","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S146114571200154X","article-title":"Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity","volume":"16","author":"Sesia","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib855","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1177\/0269881119878177","article-title":"Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial","volume":"33","author":"Shalbafan","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib856","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1017\/S1092852900006805","article-title":"Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder","volume":"4","author":"Shannahoff-Khalsa","year":"1999","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib10011","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00793","article-title":"Kundalini yoga meditation versus the relaxation response meditation for treating adults with obsessive-compulsive disorder: A randomized clinical trial","volume":"10","author":"Shannahoff-Khalsa","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib857","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1520-6394(1997)6:4<170::AID-DA7>3.0.CO;2-G","article-title":"Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder","volume":"6","author":"Shapira","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib858","doi-asserted-by":"crossref","DOI":"10.1017\/S1352465803002066","article-title":"Geographic inequity in the availability of cognitive behavioural therapy in England and Wales","author":"Shapiro","year":"2003","journal-title":"Behav. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib859","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/YIC.0000000000000267","article-title":"Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study","volume":"34","author":"Sharafkhah","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib860","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703701","article-title":"Comorbidities in obsessive-compulsive disorder across the lifespan: A systematic review and meta-analysis","volume":"12","author":"Sharma","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib861","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102183","article-title":"Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder","author":"Sharma","year":"2020","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib862","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2217\/WHE.15.20","article-title":"Obsessive-compulsive disorder in the postpartum period: diagnosis, differential diagnosis and management","volume":"11","author":"Sharma","year":"2015","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib863","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jad.2014.12.019","article-title":"Comorbid obsessive compulsive disorder in patients with bipolar-I disorder","volume":"174","author":"Shashidhara","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib864","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.comppsych.2005.09.001","article-title":"Clinical features associated with treatment response in obsessive-compulsive disorder","volume":"47","author":"Shavitt","year":"2006","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2014.06.010","article-title":"Phenomenology of OCD: Lessons from a large multicenter study and implications for ICD-11","author":"Shavitt","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib866","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00406-009-0015-3","article-title":"The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder","volume":"260","author":"Shavitt","year":"2010","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib867","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000457128","article-title":"Repetitive transcranial magnetic stimulation improved symptoms of obsessive-compulsive disorders but not executive functions: Results from a randomized clinical trial with crossover design and sham condition","volume":"74","author":"Shayganfard","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib868","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"j4008","author":"Shea","year":"2017","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.039_bib869","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.113.203315","article-title":"Modulation of the antidepressant-like effects of sustained administration of carisbamate and lamotrigine on monoaminergic systems: electrophysiological studies in the rat brain","volume":"347","author":"Shim","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib870","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2009.83","article-title":"The neurocircuitry of fear, stress, and anxiety disorders","author":"Shin","year":"2010","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib871","series-title":"Corrigendum to \u201cMusic therapy as an adjunct to standard treatment for obsessive compulsive disorder and co-morbid anxiety and depression: A randomized clinical trial.\u201d","author":"Shiranibidabadi","year":"2017"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib872","first-page":"156","article-title":"Postpartum obsessive compulsive disorder: a case series","volume":"54","author":"Sichel","year":"1993","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib873","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neubiorev.2018.01.001","article-title":"Treatment of PANDAS and PANS: a systematic review","volume":"86","author":"Sigra","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib874","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJMoa2103583","article-title":"Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder","volume":"385","author":"Sikich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib875","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.4088\/JCP.v58n0802","article-title":"A Double-Blind Trial of Fluoxetine in Pathologic Skin Picking","volume":"58","author":"Simeon","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib876","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/cap.2021.0137","article-title":"Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors","volume":"32","author":"Simonoff","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib877","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","article-title":"Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib878","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/appi.ajp.2007.07091440","article-title":"A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder","volume":"165","author":"Simpson","year":"2008","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib879","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4088\/JCP.v67n0214","article-title":"Response versus remission in obsessive-compulsive disorder","volume":"67","author":"Simpson","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib880","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4088\/JCP.v60n0904","article-title":"Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: An Open Trial","volume":"60","author":"Simpson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib881","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/a0022659","article-title":"Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder","volume":"79","author":"Simpson","year":"2011","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib882","doi-asserted-by":"crossref","DOI":"10.1590\/1516-4446-2013-1229","article-title":"Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers","author":"Simpson","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib883","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/16506073.2012.751124","article-title":"Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders","volume":"42","author":"Simpson","year":"2013","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib884","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/16506070701743252","article-title":"Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial","volume":"37","author":"Simpson","year":"2008","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib885","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.brat.2010.05.026","article-title":"Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder","volume":"48","author":"Simpson","year":"2010","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib886","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20430","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children\/adolescents and adults","volume":"20","author":"Skapinakis","year":"2016","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib887","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/appi.focus.19402","article-title":"Pharmacological and Psychotherapeutic Interventions for Management of Obsessive-compulsive Disorder in Adults: A Systematic Review and Network Meta-analysis","volume":"19","author":"Skapinakis","year":"2021","journal-title":"FOC"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib888","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2006.07.002","article-title":"Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials","author":"Skapinakis","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib889","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08039488.2014.941395","article-title":"Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons","volume":"69","author":"Skarphedinsson","year":"2015","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib890","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/cap.2015.0041","article-title":"Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder","volume":"25","author":"Skarphedinsson","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib891","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00787-014-0613-0","article-title":"Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial","volume":"24","author":"Skarphedinsson","year":"2014","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib892","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archpsyc.56.2.121","article-title":"A 40-year follow-up of patients with obsessive-compulsive disorder","volume":"56","author":"Skoog","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib893","article-title":"Younger versus older children with obsessive-compulsive disorder: Symptoms, severity, and impairment","volume":"29","author":"Sm\u00e1rason","year":"2021","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib894","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti\u2010attention\u2010deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta\u2010review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib895","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib896","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/hup.1145","article-title":"A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder","volume":"25","author":"Soltani","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib897","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/17425255.2014.885504","article-title":"Clinically relevant interactions between newer antidepressants and second-generation antipsychotics","volume":"10","author":"Spina","year":"2014","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib898","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00926239308404898","article-title":"Sexual history and quality of current relationships in patients with obsessive compulsive disorder: A comparison with two other psychiatric samples","volume":"19","author":"Staebler","year":"1993","journal-title":"J. Sex Marital Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib899","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S1516-44462007000400003","article-title":"Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo","volume":"29","author":"Stein","year":"2007","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib900","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1185\/030079907X178838","article-title":"Escitalopram in obsessive\u2013compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study","volume":"23","author":"Stein","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib901","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02900220","article-title":"Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania","volume":"247","author":"Stein","year":"1997","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib902","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S1092852900016722","article-title":"Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy","volume":"13","author":"Stein","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib903","doi-asserted-by":"crossref","DOI":"10.1002\/da.20699","article-title":"Should OCD be classified as an anxiety disorder in DSM-V?","author":"Stein","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib904","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/da.22163","article-title":"Family aggregation and risk factors of obsessive-compulsive disorders in a nationwide three-generation study","volume":"30","author":"Steinhausen","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib905","series-title":"The Oxford handbook of obsessive compulsive and spectrum disorders","author":"Steketee","year":"2011"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib906","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-1781(99)00104-3","article-title":"Predictors of course in obsessive compulsive disorder","volume":"89","author":"Steketee","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib907","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0887-6185(91)90035-R","article-title":"Religion and guilt in OCD patients","volume":"5","author":"Steketee","year":"1991","journal-title":"J. Anxiety Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.12.039_bib908","doi-asserted-by":"crossref","DOI":"10.1300\/J085v14n04_06","article-title":"Family Approaches to Treatment for Obsessive Compulsive Disorder","volume":"14","author":"Steketee","year":"2004","journal-title":"J. Fam. Psychother."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2025.12.039_bib909","first-page":"134","article-title":"Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis","volume":"56","author":"Stern","year":"1980","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib910","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2004.00302.x","article-title":"Long term outcome of pediatric obsessive compulsive disorder: A meta-analysis and qualitative review of the literature","volume":"110","author":"Stewart","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib911","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaac.2016.12.012","article-title":"A multisite study of family functioning impairment in pediatric obsessive-compulsive disorder","volume":"56","author":"Stewart","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib912","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","article-title":"Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis","volume":"47","author":"Stogios","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib913","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1521\/bumc.2010.74.2.167","article-title":"Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder","volume":"74","author":"Storch","year":"2010","journal-title":"Bull. Menninger Clin."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib914","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psychres.2011.05.047","article-title":"Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder","volume":"189","author":"Storch","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib915","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15374410701277929","article-title":"Family accommodation in pediatric obsessive-compulsive disorder","volume":"36","author":"Storch","year":"2007","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib916","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.12m08278","article-title":"Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder","author":"Storch","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib917","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2023.104451","article-title":"Randomized trial comparing standard versus light intensity parent training for anxious youth","volume":"173","author":"Storch","year":"2024","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib918","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jclp.20382","article-title":"Florida Obsessive-Compulsive Inventory: development, reliability, and validity","volume":"63","author":"Storch","year":"2007","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib919","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10578-009-0138-9","article-title":"Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth","volume":"40","author":"Storch","year":"2009","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib920","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/15374410903532676","article-title":"An Open Trial of Intensive Family Based Cognitive-Behavioral Therapy in Youth With Obsessive-Compulsive Disorder Who Are Medication Partial Responders or Nonresponders","volume":"39","author":"Storch","year":"2010","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib921","series-title":"The clinician's guide to cognitive-behavioral therapy for childhood obsessive-compulsive disorder","author":"Storch","year":"2018"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib922","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaac.2018.05.029","article-title":"Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition","volume":"58","author":"Storch","year":"2019","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib923","doi-asserted-by":"crossref","DOI":"10.1097\/CHI.0b013e31816774b1","article-title":"Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder","author":"Storch","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib924","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jpsychires.2020.10.023","article-title":"Moderators and predictors of response to deep transcranial magnetic stimulation for obsessive-compulsive disorder","volume":"136","author":"Storch","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib925","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2016.1128","article-title":"Efficacy of augmentation of cognitive behavior therapy with weight-adjusted d-cycloserine vs placebo in pediatric obsessive-compulsive disorder: A randomized clinical trial","author":"Storch","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib926","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2018.04.007","article-title":"Mindfulness-based exposure and response prevention for obsessive compulsive disorder: Findings from a pilot randomised controlled trial","author":"Strauss","year":"2018","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib927","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/da.22329","article-title":"Efficacy and tolerability of antidepressants in pediatric anxiety disorders: A systematic review and meta\u2010analysis","volume":"32","author":"Strawn","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib928","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1176\/ajp.152.8.1192","article-title":"A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania","volume":"152","author":"Streichenwein","year":"1995","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib929","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-025-02189-z","article-title":"Genome-wide analyses identify 30 loci associated with obsessive\u2013compulsive disorder","author":"Strom","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib930","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01519-z","article-title":"A dimensional perspective on the genetics of obsessive-compulsive disorder","author":"Strom","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib931","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/YIC.0b013e32835bd24e","article-title":"Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study","volume":"28","author":"Stryjer","year":"2013","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib932","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2147\/NDT.S276635","article-title":"Transcranial magnetic stimulation (TMS) safety with respect to seizures: A literature review","volume":"16","author":"Stultz","year":"2020","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib933","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011144.pub2","article-title":"Methylphenidate for children and adolescents with autism spectrum disorder","author":"Sturman","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib934","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40263-013-0056-z","article-title":"Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment","volume":"27","author":"Subramaniam","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib935","article-title":"Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health, CBHSQ Methodology Report","year":"2016","journal-title":"Substance Abuse and Mental Health Services Administration (US), Rockville (MD)"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib936","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2017.04.068","article-title":"Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis","volume":"218","author":"Sugarman","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib937","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2022.2082525","article-title":"Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials","volume":"24","author":"Suhas","year":"2023","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib938","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-0665.1000113","article-title":"From research subgroup to clinical syndrome: Modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome)","volume":"2","author":"Swedo","year":"2012","journal-title":"Pediatr. Therapeut."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib939","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib940","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198908243210803","article-title":"A Double-Blind Comparison of Clomipramine and Desipramine in the Treatment of Trichotillomania (Hair Pulling)","volume":"321","author":"Swedo","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib941","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archpsyc.1989.01810040041007","article-title":"Obsessive-compulsive disorder in children and adolescents: Clinical phenomenology of 70 consecutive cases","volume":"46","author":"Swedo","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib942","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.schres.2013.10.033","article-title":"The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates","volume":"152","author":"Swets","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib943","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2022.01.057","article-title":"Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis","volume":"148","author":"Tao","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib944","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","first-page":"572","article-title":"Increased mortality with antipsychotic drugs in dementia","author":"Taylor","year":"2018"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib945","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v61n0806","article-title":"An Open-Label Trial of St. John's Wort (Hypericum perforatum) in Obsessive-Compulsive Disorder","volume":"61","author":"Taylor","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib946","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cpr.2011.06.007","article-title":"Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib947","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102625","article-title":"Transcranial direct current stimulation for treatment-resistant obsessive-compulsive disorder\u2014A large case series","author":"Thamby","year":"2021","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib948","first-page":"47","article-title":"The schedule for assessment of psychiatric disability-a modification of the das-ii","volume":"30","author":"Thara","year":"1988","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib949","doi-asserted-by":"crossref","DOI":"10.1089\/cap.2016.0145","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome: Part I-psychiatric and behavioral interventions","author":"Thienemann","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib950","doi-asserted-by":"crossref","DOI":"10.1016\/j.beth.2014.11.001","article-title":"A randomized clinical trial of a brief family intervention to reduce accommodation in obsessive-compulsive disorder: a preliminary study","author":"Thompson-Hollands","year":"2015","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib951","series-title":"Obsessive-compulsive disorders","author":"Thomsen","year":"2013"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib952","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10401230490522016","article-title":"Risperidone Augmentation in the Treatment of Severe Adolescent OCD in SSRI-refractory Cases: A Case-series","volume":"16","author":"Thomsen","year":"2004","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib953","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archpsyc.1980.01780240079009","article-title":"Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial","volume":"37","author":"Thoren","year":"1980","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib954","first-page":"1049","article-title":"Improvement of obsessions and compulsions with clozapine in an individual with schizophrenia","volume":"44","author":"Tibbo","year":"1999","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib955","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12888-024-05780-6","article-title":"Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder","volume":"24","author":"Tjelle","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib956","article-title":"Immediate effects of transcranial direct current stimulation on obsession-induced anxiety in refractory obsessive-compulsive disorder: A pilot study","author":"Todder","year":"2017","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib957","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.4088\/JCP.v65n0708","article-title":"Cognitive-Behavioral Therapy for Medication Nonresponders With Obsessive-Compulsive Disorder: A Wait-List-Controlled Open Trial","volume":"65","author":"Tolin","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. l","key":"10.1016\/j.jpsychires.2025.12.039_bib958","first-page":"69","article-title":"Continuation treatment of OCD: double-blind and open-label experience with fluoxetine","volume":"55","author":"Tollefson","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib959","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jnnp-2020-323028","article-title":"Paternal exposure to antiepileptic drugs and offspring outcomes: a nationwide population-based cohort study in Sweden","volume":"91","author":"Tomson","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib960","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12311-014-0561-8","article-title":"Late-onset obsessive-compulsive disorder associated with left cerebellar lesion","volume":"13","author":"Tonna","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib961","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113715","article-title":"Pattern of occurrence of obsessive-compulsive symptoms in bipolar disorder","volume":"297","author":"Tonna","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib962","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/wps.20592","article-title":"Towards a consensus around standards for smartphone apps and digital mental health","volume":"18","author":"Torous","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib963","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaac.2014.12.007","article-title":"Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder","volume":"54","author":"Torp","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib964","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.comppsych.2008.05.005","article-title":"Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil","volume":"50","author":"Torresan","year":"2009","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib965","year":"2013"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib966","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/YCT.0000000000000335","article-title":"Transcranial magnetic stimulation for obsessive-compulsive disorder: An updated systematic review and meta-analysis","volume":"32","author":"Trevizol","year":"2016","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib967","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5498\/wjp.v6.i4.449","article-title":"Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: Systematic review of evidence","volume":"6","author":"Tundo","year":"2016","journal-title":"WJP"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib968","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaac.2014.09.012","article-title":"Telephone Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Non-inferiority Trial","volume":"53","author":"Turner","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib969","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ntr\/nty055","article-title":"Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy","volume":"21","author":"Turner","year":"2019","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib970","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2018.06.005","article-title":"Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial","author":"Twohig","year":"2018","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib971","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1037\/a0020508","article-title":"A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder","volume":"78","author":"Twohig","year":"2010","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib972","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biopsych.2019.01.017","article-title":"A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: Clinical and imaging evidence for dissociable effects","volume":"85","author":"Tyagi","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib973","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1590\/1516-4446-2015-1673","article-title":"Pharmacotherapy of obsessive-compulsive disorder during pregnancy: A clinical approach","volume":"37","author":"Uguz","year":"2015","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib974","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.janxdis.2007.10.001","article-title":"Self-, parent-report and interview measures of obsessive\u2013compulsive disorder in children and adolescents","volume":"22","author":"Uher","year":"2008","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib975","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaac.2019.08.480","article-title":"Systematic review and meta-analysis: Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents","volume":"59","author":"Uhre","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib976","series-title":"Exposed Children","article-title":"FDA Drug Safety Communication: Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women due to Decreased IQ Scores","year":"2016"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib977","first-page":"603","article-title":"Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of obsessive- compulsive disorder - A double-blind, placebo controlled trial","volume":"19","author":"Ushijima","year":"1997","journal-title":"Japanese Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib978","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0269881108098809","article-title":"Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report","volume":"24","author":"Uzun","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib979","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2012.02.002","article-title":"Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?","volume":"139","author":"Valerio","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib980","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41398-021-01329-3","article-title":"Lithium: a potential therapeutic strategy in obsessive-compulsive disorder by targeting the canonical WNT\/beta pathway","volume":"11","author":"Vallee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib981","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00004583-199607000-00015","article-title":"Incidence of obsessive-compulsive disorder in a community sample of young adolescents","volume":"35","author":"Valleni-Basile","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib982","doi-asserted-by":"crossref","DOI":"10.1002\/da.20118","article-title":"Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series","author":"Van Ameringen","year":"2006","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib983","doi-asserted-by":"crossref","DOI":"10.1002\/da.22259","article-title":"DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria","author":"Van Ameringen","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib984","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.09m05114gre","article-title":"A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania","volume":"71","author":"van Ameringen","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib985","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00005053-199808000-00007","article-title":"Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder","volume":"186","author":"van Balkom","year":"1998","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib986","first-page":"366","article-title":"Cognitive Therapy versus Fluvoxamine as a Second-Step Treatment in Obsessive-Compulsive Disorder Nonresponsive to First-Step Behavior Therapy","volume":"81","author":"van Balkom","year":"2012","journal-title":"PPS"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib987","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/mhj.2002.123580","article-title":"Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT)","volume":"144","author":"van den Brink","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib988","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jocrd.2016.02.002","article-title":"Metacognitive therapy for obsessive\u2013compulsive disorder: A pilot study","volume":"9","author":"van der Heiden","year":"2016","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib989","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0005-7967(94)00052-L","article-title":"Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder","volume":"33","author":"van Oppen","year":"1995","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib990","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder","volume":"55","author":"Varigonda","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib991","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2006.07.014","article-title":"Prenatal, perinatal, and postnatal risk factors in obsessive\u2013compulsive disorder","volume":"61","author":"Vasconcelos","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib992","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s10803-018-3772-x","article-title":"Functional Behavior-Based Cognitive-Behavioral Therapy for Obsessive Compulsive Behavior in Children with Autism Spectrum Disorder: A Randomized Controlled Trial","volume":"50","author":"Vause","year":"2020","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib993","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-014-0317-5","article-title":"Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib994","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jocrd.2015.11.005","article-title":"Outcomes for residential or inpatient intensive treatment of obsessive\u2013compulsive disorder: A systematic review and meta-analysis","volume":"8","author":"Veale","year":"2016","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib995","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jbtep.2015.03.003","article-title":"Imagery Rescripting for Obsessive Compulsive Disorder: A single case experimental design in 12 cases","volume":"49","author":"Veale","year":"2015","journal-title":"J. Behav. Ther. Exp. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib996","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S1041610205002735","article-title":"Late-onset obsessive-compulsive disorder: the role of stressful life events","volume":"18","author":"Velayudhan","year":"2006","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib997","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpsy.2016.05.003","article-title":"The suicidality continuum in a large sample of obsessive-compulsive disorder (OCD) patients","author":"Velloso","year":"2016","journal-title":"Eur. Psychiatry : J. Assoc. European Psychiatrists"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib998","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.07.2008.0462","article-title":"Scurvy induced by obsessive-compulsive disorder","volume":"2009","author":"Vieira","year":"2009","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib999","author":"Vigod","year":"2025","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1000","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2298","article-title":"Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study","volume":"350","author":"Vigod","year":"2015","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0020764009347333","article-title":"Psychosocial impact of obsessive-compulsive disorder on patients and their caregivers: a comparative study with depressive disorder","volume":"57","author":"Vikas","year":"2011","journal-title":"Int. J. Soc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/appi.focus.130117","article-title":"The Risk of Switch to Mania in Patients With Bipolar Disorder During Treatment With an Antidepressant Alone and in Combination With a Mood Stabilizer","volume":"13","author":"Viktorin","year":"2015","journal-title":"FOC"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jocrd.2017.03.003","article-title":"The impact of poor insight on the course of obsessive-compulsive disorder in patients receiving naturalistic treatment","volume":"13","author":"Visser","year":"2017","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1004","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113721","article-title":"Prevalence and onset of anxiety and related disorders throughout pregnancy: A prospective study in an Australian sample","volume":"297","author":"Viswasam","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2019.05.016","article-title":"Prevalence, onset and course of anxiety disorders during pregnancy: A systematic review and meta analysis","volume":"255","author":"Viswasam","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brat.2014.10.007","article-title":"A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder","volume":"63","author":"Vogel","year":"2014","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1007","doi-asserted-by":"crossref","DOI":"10.1017\/S1352465804001353","article-title":"Adding cognitive therapy elements to exposure therapy for obsessive compulsive disorder: a controlled study","author":"Vogel","year":"2004","journal-title":"Behav. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1008","article-title":"Antidepressant Remission and Manic Switch in Bipolar Depression: A Propensity Score Analysis","volume":"13822","author":"V\u00f6hringer","year":"2025","journal-title":"Acta Psychiatr Scand acps"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-1781(85)90092-7","article-title":"Clomipramine and imipramine in obsessive-compulsive disorder","volume":"14","author":"Volavka","year":"1985","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1010","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.biopsych.2004.11.006","article-title":"Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit\/hyperactivity disorder","volume":"57","author":"Volkow","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1011","doi-asserted-by":"crossref","DOI":"10.1080\/13554794.2012.667131","article-title":"Modulation of affective symptoms and resting state activity by brain stimulation in a treatment-resistant case of obsessive-compulsive disorder","author":"Volpato","year":"2013","journal-title":"Neurocase"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1012","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000070785","article-title":"Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial","volume":"72","author":"Volpato Cordioli","year":"2003","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1013","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000478025","article-title":"The history and future of ablative neurosurgery for major depressive disorder","volume":"95","author":"Volpini","year":"2017","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1014","article-title":"Tic-related versus tic-free obsessive-compulsive disorder: Clinical picture and 2-year natural course","author":"Vries","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/104454603322126340","article-title":"Remission Status After Long-Term Sertraline Treatment of Pediatric Obsessive-Compulsive Disorder","volume":"13","author":"Wagner","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1016","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-4642(19)30376-1","article-title":"Early detection and intervention for obsessive-compulsive disorder in childhood and adolescence","author":"Walitza","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00702-007-0841-2","article-title":"Children and adolescents with obsessive-compulsive disorder and comorbid attention-deficit\/hyperactivity disorder: preliminary results of a prospective follow-up study","volume":"115","author":"Walitza","year":"2008","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.12.039_bib1018","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jad.2011.11.001","article-title":"Cross-sectional comparison of the clinical characteristics of adults with early-onset and late-onset obsessive compulsive disorder","volume":"136","author":"Wang","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1019","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1017\/S003329171900401X","article-title":"The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis","volume":"51","author":"Wang","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jad.2014.12.025","article-title":"Treatment-as-usual (TAU) is anything but usual: A meta-analysis of CBT versus TAU for anxiety and depression","volume":"175","author":"Watts","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1021","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jclp.22394","article-title":"Treatment of a Child With Obsessive-Compulsive Disorder With Limited Motivation: Course and Outcome of Cognitive-Behavior Therapy","volume":"72","author":"Weidle","year":"2016","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1022","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/jnp.12.2.265","article-title":"Late-onset obsessive-compulsive disorder: a case series","volume":"12","author":"Weiss","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/16506073.2012.701663","article-title":"Differences in Obsessive\u2013Compulsive Symptoms and Obsessive Beliefs: A Comparison between African Americans, Asian Americans, Latino Americans, and European Americans","volume":"42","author":"Wheaton","year":"2013","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1024","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.brat.2004.11.012","article-title":"Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention","volume":"43","author":"Whittal","year":"2005","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2009.11.010","article-title":"Treatment of obsessions: a randomized controlled trial","author":"Whittal","year":"2010","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1026","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2022.100520","article-title":"Feasibility of internet-delivered cognitive-behavior therapy for obsessive-compulsive disorder in youth with autism spectrum disorder: A clinical benchmark study","volume":"28","author":"Wickberg","year":"2022","journal-title":"Internet Interventions"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1027","first-page":"341","article-title":"Geriatric depression: the use of antidepressants in the elderly","volume":"53","author":"Wiese","year":"2011","journal-title":"BC Med J"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13651501.2017.1354029","article-title":"Autism spectrum disorders in adult outpatients with obsessive compulsive disorder in the UK","volume":"22","author":"Wikramanayake","year":"2018","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1029","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/02791072.2014.963754","article-title":"Psilocybin and obsessive compulsive disorder","volume":"46","author":"Wilcox","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2018.07.042","article-title":"D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome","author":"Wilhelm","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1031","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1891\/0889-8391.23.4.294","article-title":"Modular cognitive therapy for obsessive-compulsive disorder: A wait-List controlled trial","volume":"23","author":"Wilhelm","year":"2009","journal-title":"J. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1032","series-title":"Cognitive therapy for obsessive-compulsive disorder: A guide for professionals","author":"Wilhelm","year":"2006"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beth.2019.03.007","article-title":"Development and pilot testing of a cognitive-behavioral therapy digital service for body dysmorphic disorder","volume":"51","author":"Wilhelm","year":"2020","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1034","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaac.2016.06.017","article-title":"Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"55","author":"Williams","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/13554794.2015.1112019","article-title":"Reward circuit DBS improves Parkinson's gait along with severe depression and OCD","volume":"22","author":"Williams","year":"2016","journal-title":"Neurocase"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1036","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.brs.2021.02.013","article-title":"Accelerated neuromodulation therapy for Obsessive-Compulsive Disorder","volume":"14","author":"Williams","year":"2021","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/eb-2017-102718","article-title":"A systematic review of network meta-analyses for pharmacological treatment of common mental disorders","volume":"21","author":"Williams","year":"2018","journal-title":"Evid. Base Ment. Health"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2020.100592","article-title":"Cross-cultural differences in the presentation and expression of OCD in Black individuals: A systematic review","volume":"27","author":"Wilson","year":"2020","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1039","first-page":"304","article-title":"Clinical characteristics of trichotillomania and its response to fluoxetine","volume":"53","author":"Winchel","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1040","first-page":"357","article-title":"Size and burden of mental disorders in Europe\u2014a critical review and appraisal of 27 studies","volume":"15","author":"Wittchen","year":"2005","journal-title":"European Neuropsychopharmacology, Size & Burden of Mental Disorders in Europe"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1041","article-title":"Brief intensive cognitive behavioral therapy for children and adolescents with OCD: Two international pilot studies","volume":"29","author":"Wolters","year":"2021","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1042","article-title":"Dexamphetamine for Obsessive-Compulsive Disorder","volume":"160","author":"Woolley","year":"2003","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2015.10.001","article-title":"Remote cognitive-behavior therapy for obsessive-compulsive symptoms: A meta-analysis","author":"Wootton","year":"2016","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1044","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2015.05.003","article-title":"Self-guided internet-delivered cognitive behavior therapy (iCBT) for obsessive\u2013compulsive disorder: 12 month follow-up","author":"Wootton","year":"2015","journal-title":"Internet Interventions"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocrd.2013.07.002","article-title":"Remote treatment of obsessive-compulsive disorder: A randomized controlled trial","author":"Wootton","year":"2013","journal-title":"J. Obsessive-Compulsive Related Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1046","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2021.102444","article-title":"Internet-delivered cognitive-behaviour therapy (ICBT) for obsessive-compulsive disorder when delivered as routine clinical care: A phase IV clinical trial","volume":"82","author":"Wootton","year":"2021","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1048","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41380-020-00933-x","article-title":"Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?","volume":"26","author":"Wu","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1049","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10578-019-00876-7","article-title":"Comorbid psychopathology and the clinical profile of family accommodation in pediatric OCD","volume":"50","author":"Wu","year":"2019","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1051","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/089198870001300107","article-title":"Fluvoxamine Pharmacotherapy of Anxiety Disorders in Later Life: Preliminary Open-Trial Data","volume":"13","author":"Wylie","year":"2000","journal-title":"J. Geriatr. Psychiatr. Neurol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1052","article-title":"D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis","author":"Xia","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1053","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1176\/appi.ajp.2020.19070698","article-title":"Antibodies from children with PANDAS bind specifically to striatal cholinergic interneurons and alter their activity","volume":"178","author":"Xu","year":"2021","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1054","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2009.77","article-title":"Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection","author":"Yaddanapudi","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3171\/2021.11.JNS21928","article-title":"Deep brain stimulation for extreme behaviors associated with autism spectrum disorder converges on a common pathway: a systematic review and connectomic analysis","volume":"137","author":"Yan","year":"2022","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1056","first-page":"541","article-title":"Chlorimipramine, for obsessive-compulsive neurosis: An organic approach","volume":"20","author":"Yaryura-Tobias","year":"1976","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1057","series-title":"Obsessive-compulsive Disorder Spectrum: Pathogenesis, Diagnosis, and Treatment","author":"Yaryura-Tobias","year":"1997"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1058","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archpsyc.1996.01830070103016","article-title":"Venlafaxine in obsessive-compulsive disorder","volume":"53","author":"Yaryura-Tobias","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1059","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa2300184","article-title":"Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression","volume":"389","author":"Yatham","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1061","first-page":"185","article-title":"Transcranial direct current stimulation of dorsolateral prefrontal cortex in patients with obsessive compulsive disorder to improve decision making and reduce obsession symptoms","volume":"3","author":"Yekta","year":"2015","journal-title":"PCP"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1062","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-020-02979-1","article-title":"The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial","author":"Yoosefee","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1063","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40272-024-00639-5","article-title":"Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges","volume":"26","author":"Younus","year":"2024","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1064","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/YIC.0000000000000321","article-title":"5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control","volume":"35","author":"Yousefzadeh","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00048670802050546","article-title":"Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder","volume":"42","author":"Yucel","year":"2008","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1066","doi-asserted-by":"crossref","DOI":"10.1177\/1073858409336227","article-title":"Noninvasive brain stimulation with low-intensity electrical currents: putative mechanisms of action for direct and alternating current stimulation","author":"Zaghi","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1067","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2217\/pgs.14.83","article-title":"Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians","volume":"15","author":"Zai","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1068","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0145445520982977","article-title":"A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran","volume":"46","author":"Zemestani","year":"2022","journal-title":"Behav. Modif."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1069","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/1099-9809.5.2.134","article-title":"Ethnic characteristics of mental disorders in five US communities","volume":"5","author":"Zhang","year":"1999","journal-title":"Cult. Divers Ethnic Minor. Psychol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1070","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2147\/NDT.S209319","article-title":"Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder","volume":"15","author":"Zhang","year":"2019","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1071","article-title":"Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1072","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/429412","article-title":"Neural acupuncture unit: a new concept for interpreting effects and mechanisms of acupuncture","volume":"2012","author":"Zhang","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1073","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.euroneuro.2018.12.010","article-title":"Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study","volume":"29","author":"Zheng","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1074","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2017.03.033","article-title":"An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder","volume":"215","author":"Zhou","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2018.12.009","article-title":"Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis","author":"Zhou","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1076","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2019.01.014","article-title":"Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: A network meta-analysis","author":"Zhou","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1077","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaac.2020.03.007","article-title":"Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders","volume":"60","author":"Zhou","year":"2021","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1078","first-page":"439","article-title":"Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder","volume":"111","author":"Zitterl","year":"1999","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1079","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1192\/bjp.169.4.468","article-title":"Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators","volume":"169","author":"Zohar","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.039_bib1080","first-page":"385","article-title":"Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients","volume":"54","author":"Zohar","year":"1993","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 14","key":"10.1016\/j.jpsychires.2025.12.039_bib1081","first-page":"18","article-title":"Serotonin-1D hypothesis of obsessive-compulsive disorder: an update","volume":"65","author":"Zohar","year":"2004","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239562500785X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239562500785X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:42:08Z","timestamp":1779986528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239562500785X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":1076,"alternative-id":["S002239562500785X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.12.039","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}